Genetically Modified Food, Intellectual Property, and Food Security in Africa. by Asamoah-Boakye, Gabriel
1 
 
UNIVERSITY OF TURKU 
Faculty of Law 
ASAMOAH-BOAKYE GABRIEL: Genetically Modified Food, Intellectual Property, and 
     Food Security in Africa. 
Master’s thesis, 85p., 1 appendix 
Master Degree Programme in Law and Information Society 
December 2019 
 
As food insecurity continues to be a cardinal concern in Africa, many alternatives including, 
the use of GMOs have been proposed as an exemplar for addressing the challenge. While a 
single measure may not be enough, this paper, in brief, looks at the use of Genetically modified 
organisms as a mechanism for combating food insecurity in Africa, particularly the role 
intellectual property plays as the new fulcrum in the biotech industry debates.  
As a growing field, GMOs are regulated differently across the world. The paper first looks at 
the various international and regional regulatory frameworks that govern GMO, their general 
outlook, how they came into being, and how they are affecting the systems being crafted and 
implemented in Africa. Specifically, the CBD-CPB, TRIPS agreement, and UPOV convention 
are considered together with the different regulatory approaches that the US and EU have 
adopted on GMO even though both have similar intellectual property protections for biotech 
innovations. 
The question of how GMOs should be protected to guarantee rights of developers while not 
hindering access to food is further analysed under the scope, objectives, and exceptions of plant 
patents and other sui-generis protection models that are available to African countries in their 
quest to have a balanced system that works. The paper concludes that although 
biotechnological improvements have stabilized the breeding process and fortified the demand 
for patent protections, sui-generis protection may be more suitable for the African food 
production climate. And luckily, nations need not reinvent the wheel instead. 
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Lipton (1999) argued that Too many people still have no or too little to eat. 
1.0 INTRODUCTION 
In 2018, the United Nations estimated that most of the over 783 million people who live below 
the poverty line are either in Africa or southern Asia. Its studies over the same period also 
estimated that about 233 million (from the 175 million in 2010) of the 795 million people 
worldwide who are either hungry or undernourished are in Africa; particularly Sub-Saharan 
Africa.1 And even though trend analysis over the past decade indicates that the world food 
crisis has improved, food insecurity is an existential threat to Africa and other areas of the 
world.2  This notwithstanding, in 2007, many African countries amidst high food insecurity 
concerns, rejected food aid from the UN because it contained Genetically Modified Organisms 
(GMOs). The rejection raises at least two critical issues: acceptability of GM (despite its 
potential for solving hunger) and; the framework that will facilitate the short term flow and 
long term growth of GM.3 This research looks at the role GMO play in ensuring food security 
as well as the challenges it brings.  
Food security is realized “when all people, at all times, have physical, social and economic 
access to sufficient, safe and nutritious food which meets their dietary needs and food 
preferences for an active and healthy life.”4 This concept can be applied at the family/ 
household level as well as the national, regional, and global levels. To achieve household food 
security, the concerns of the individuals within the household is the focus. Food insecurity as 
such exists when physical, social and economic factors limit access to food.5 The Ryerson 
Centre also integrates access to foods that are culturally acceptable and in a way that human 
dignity is upheld into the meaning of food security.6  Food security, therefore, goes beyond 
 
1 The State of Food Insecurity in the World 2016. Meeting the 2015 International Hunger Targets: Taking Stock 
of Uneven Progress (FAO, IFAD and WFP, 2015) p. 8. https://www.worldhunger.org/africa-hunger-poverty-
facts/, http://www.un.org/en/sections/issues-depth/poverty/ 
2 The State of Food Security and Nutrition in the World. Building Climate Resilience for food security and 
nutrition 2018, ISBN 978-92-5-13057-3 FOA Report. 
3 Jamil K. 2018, Biotechnology - a Solution To Hunger? https://www.un.org/en/chronicle/article/biotechnology-
solution-hunger 
4 Anema, A., Fielden, S. J., Shurgold, S., Ding, E., Messina, J., Jones, J. E., ... & Hogg, R. S. (2016). Association 
between food insecurity and procurement methods among people living with HIV in a high resource setting. PloS 
one, 11(8), e0157630.. 
5 Rome Declaration on World Food Security and World Food Summit Plan of Action, adopted at the World Food 
Summit, Rome, 13–17 November 1996, at http://www.fao.org/docrep/003/w3613e/w3613e00.HTM.   
6 Vahabi, M., & Damba, C. (2013). Perceived barriers in accessing food among recent Latin American immigrants 
in Toronto. International journal for equity in health, 12(1), 1. 
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merely providing food to malnourished or undernourished people to include other cultural and 
religious considerations.  
Previous Food Security Summit discussions focused on availability and overlooked the core 
element of access under the presumption that the poor countries would be able to afford food 
once they were available for purchase. It was the FAO summit in 1983 that, however, brought 
attention to the need to consider the challenges at both the demand and supply sides. 
Subsequent debates on the subject broadened the concept of access to include the notion of 
sufficient food, food safety, nutritional balance and cultural appropriateness. The concept of 
food security was expanded and accordingly re-defined in view of this.  Recent food security 
studies have, in addition to access, identified availability, acceptability, adequacy and the 
agencies that facilitate food security realisation as critical factors.7 
The reasons for food insecurity are varied and diverse, many have suggested that Population 
growth, farming practices, limited farm inputs, inadequate storage facilities, weak market 
structures, transport and distribution network from insufficient infrastructure such as roads are 
the leading causes.8 Others contend that the unfavourable commodity pricing mechanism rather 
than the type of seed remains the biggest obstacle for farmers despite the enormous food 
insecurity and poverty concerns on the continent.9 These challenges are not isolated but very 
intertwined in many respects. For example, the traditional labour-intensive farming practices 
encouraged people to procreate in many communities; having many children implied having 
more hands to work, yet, the farm produces are left to rot because of the poor transport network.  
So far, many studies have established a direct correlation between food security and 
development. It is therefore not surprising that food security has been central in the 
developmental strategies of the African region with 12 out of the 17 UN SDGs, for instance, 
reflecting the central role of nutrition in sustainable development.10 This centrality is borne out 
of the nature of resources within the continent. That is the vast expanse of the land remains 
cultivable in spite of the number of deserts, and the population are mainly farmers in rural areas 
 
7 Vahabi, M. & Damba C. ib 
8 PRESENT SITUATION OF AGRICULTURE. (n.d.). Retrieved from 
http://www.fao.org/3/Y0491e/y0491e02.htm. 
9 Sasson, A. (2012)  Food security for Africa: an urgent global challenge. Agric & Food Secur 1, 2 
doi:10.1186/2048-7010-1-2. Also see Kofi Annan former UN secretary general on food security. 
10 The Sustainable Development Goals Report 2019 United Nations 
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where agriculture is the primary source of sustenance and employment.11 Nevertheless, the 
current state of the food industry challenges the traditional ways of solving malnutrition. As 
such, several studies from organisations and researchers from all fields - economics, politics, 
agriculture, and the likes are continually developing new approaches and techniques that could 
be devised to ensure food security within the African region. Genetic Modification (GM) is 
one of the new ways suggested by many.12 
A GMO is an organism that scientists have altered by introducing alien genes or by modifying 
a plants genetic structure. The process generates proteins that give the modified organism new 
properties.13 Genetic Modification (GM) or Genetic Engineering (GE), is not just a modern 
version of the natural breeding process that we have known and practised for many thousands 
of years where plants and animals with the best attributes are used in producing offsprings, 
instead, it is a new way of creating living organisms that could never occur in nature artificially. 
GM, therefore, involves the mechanism that enables desirable characteristics or genetic 
makeups which occurs naturally to be developed through modern biotechnology techniques 
called gene technology.14 GMO include Living Modified Organism (LMO) and material 
obtained through LMO-based manufacturing and processing,  as well as organisms not capable 
of reproduction or breeding.  
The genetics of living cells, organisms and materials are synthetically altered by lab techniques 
to give them new properties that make plants resistant to diseases, insect, rodents, or drought. 
Other mechanisms make plants less susceptible to herbicides while others aim to enhance the 
quality of food or their nutritional value. Some varieties are also more friendly to the 
environment and could also increase the capacity of plants to deal with harsh weather.15 But 
the GM option is, however, not without controversy, opponents argue that GMO presents 
unknown perils to humans, animals and biodiversity.  
 
11 Voortman, R. L., Sonneveld, B. G., & Keyzer, M. A. (2003). African land ecology: Opportunities and 
constraints for agricultural development. Ambio: A Journal of the Human environment, 32(5), 367-374. 
12 Ib note 3 
13 Esvelt, K. M., Smidler, A. L., Catteruccia, F., & Church, G. M. (2014). Emerging technology: 
concerning RNA-guided gene drives for the alteration of wild populations. Elife, 3, e03401. 
14 Cockburn, A. (2002). Assuring the safety of genetically modified (GM) foods: the importance of an holistic, 
integrative approach. Journal of Biotechnology, 98(1), 79-106. 
15 FAO “FAO director-general stresses benefits of biotechnology in fighting hunger and malnutrition and calls for 
open debate on potential risks” (press release, 14 May 2001), available at: 
http://www.fao.org/WAICENT/OIS/PRESS_NE/PRESSENG/2001/pren0131.htm (last accessed 20 March 
2017). 
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Some commentators have opined that GM is not an appropriate measure for reasons like 
sustainability, they maintain that GM is an insufficient tool for curbing world hunger because 
its quick “technofix” and emphasis on monocultures has the potential of frustrating food 
sustainability and biodiversity efforts and will in the worsen world hunger in the distant 
future.16 Others argue GM crops increase the use of pesticides and herbicides because Gm 
crops become resistant to weed killers forcing farmers to use more and more, which in turn 
kills other vegetation and wildlife. This irreversibly diminishes biodiversity, contaminate and 
mutate wild plants, and undermine traditional agricultural practices. Some believe that GM is 
being used as a tool for corporate entities to take over global food supply which then increases 
hunger and poverty because farmers would get locked into buying seed GMO companies and 
only benefit large-scale entities and not small-scale farmers.17  
The general acceptance of GM in several areas have been low, perceptions, exaggerated fear 
and conflicting messages have been a significant reason for this. While lobbyists are 
overstating the gains, critics are overstating the risks. The African continent has historically 
been slow in undertaking self-tailored research as well as in accepting new agricultural 
techniques and technologies. New ways such as Genetically Modified (GM) foods have not 
been an exception even thought the use of GM products across the globe had increased 
exponentially since it was introduced in the 1990s.  
The above notwithstanding, many continue to argue that GM has the ability to revolutionise 
agriculture in a manner that guarantees sustainable growth and food security.18 But while issues 
such as the effect on biodiversity, health, among others may still be unresolved, the concerns 
Intellectual Property (IP) raises is one that is not only continually gaining centrality in GM 
discussions but responsible for shifting the current discourse on today's GM especially as a tool 
for combating food insecurity. This challenge of IP in GM is unique for several reasons; one is 
the newness of the area, the shifting landscape, and the leading players and interests that come 
to play.19  
 
16 Strauss D. M. (2007), Defying Nature: The Ethical Implications of Genetically Modified Plants, 3 J. FOOD L. 
& POL’Y 1, 8–9 (discussing the failed promise of this technology and presenting an ethical framework in support 
of labeling and monitoring) [hereinafter Strauss, Ethical Implications]. 
17 Weis, A. J., & Weis, T. (2007). The global food economy: The battle for the future of farming. Zed Books. 
18 Kariyawasam K. (2009), Legal Liability, Intellectual Property and Genetically Modified Crops: Their Impact 
on world Agriculture, researchgate.net page 9 
19 Strauss, D. M. (2009). The application of TRIPS to GMOs: international intellectual property rights and 
biotechnology. Stan. J. Int'l L., 45, 287. 
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Today, Intellectual property is widely considered as the needed mechanism that will incentivise 
and promotes innovation in the public and private sector.20 Unlike the early renaissance, crop 
science research in general and specifically GM, have moved from the public pro-bono into 
the private-profit sector.21 This move has been accompanied by the institution and adaption 
several laws and techniques that will protect private IP rights, and creating a whole new 
challenge for developing countries.22 IP potentially affects all aspects of the food chain; from 
the selection of seeds, breeding, farming, among others, especially GM foods. That is why the 
current perimeter in the battle over genetically modified organisms are showing under 
Intellectual Property Rights (IPRs).23 
Taking cognisance of the general controversies surrounding GMOs, with particular emphasis 
on Africa, this paper looks at the role IP plays in the GM industry and how this intersection 
affect access to food. The pecuniary nature of Africa’s development by itself raises issues 
fundamental issues for analysis. The nature of resources and the role agriculture plays in this 
area as the primary source of employment and sustenance makes the introduction of IP 
enveloped GM into Africa a complicated one. Africa’s internal and external relations with other 
nations and organisations, coupled with its international obligations, have severe implications 
on access to food, food security, and development. 
Therefore, the central question is, how can IP be modelled within the GM industry to improve 
food security? That is, how can the continent get the right mix of measures that ensures access 
to food and related genetic materials; transfer and development of biotechnology easier for 
food security purposes, from the policy space permissible within International commitments, 
treaty obligations, and bilateral agreement — synopsis and justification of the problem. 
 
1.2 METHODOLOGY AND SOURCES 
This paper employs the Legal formal research method in assessing the position and 
development of the law on GM and its impact on access. It will mainly analyse the agreements, 
 
20 Williams, H. L. (2013). Intellectual property rights and innovation: Evidence from the human genome. Journal 
of Political Economy, 121(1), 1-27. 
21 The earlier poverty reduction strategies between 1965 and 1984 that was said to be partly caused by the 
expansion of food staples production through poverty-oriented agricultural research particularly pro bono 
agricultural research that caused food staples to increase. 
22 Lybbert, T. J., & Sumner, D. A. (2012). Agricultural technologies for climate change in developing countries: 
Policy options for innovation and technology diffusion. Food Policy, 37(1), 114-123.  
23 Strauss D. M id 
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conventions, regulations, acts, directives, case-laws, and legislation governing intellectual 
property in GM for food and the biotechnological industry. Literature by scholars on IP, 
empirical data and findings from scientists and reputable institutions on GM, within the 
confines of access to food will also be considered.   
Although the paper is mainly qualitative, the running approach will be looking at the 
development and history; the current position of the law and how it is being implemented, 
together with; the effects of the laws on access to protected material to ensure food security.  
1.3 LIMITATION AND SIGNIFICANCE 
The GM debate is one that transcends disciplines, so is the scope and target of IP, this paper, 
however, focuses on the role IP plays within the GM and plant genetic industry. As such, the 
discussion in this paper narrows in on this intersection at the expense of the other equally 
important issues like health and safety, that have continually dominated this spectrum. 
IP is another broad area, however only the IPRs that mainly impacts the food chain is the centre 
of our attention (patents and sui-generis protections). Even though the ultimate end of this paper 
is the impact that IPR in GM have on Access to Food, the discussion focuses on food crops and 
not animals. 85% of the food is crop-based. Crop varieties like hybrid crops that may not fall 
under typical GM crops are still considered under this study due to the role IP plays in that area 
as well.    
Again, even though the issue of food insecurity is a global treat that many countries face, 
particularly developing countries, the area of this study is the African continent, it is essential 
to note that the presence or threat may not be the same for all the African countries. Other 
challenges like political instability, corruption, that plague the region is also not the subject of 
this paper. 
1.4 OUTLINE 
This paper contains five chapters. The first chapter contains the introduction that has the 
problem statement and the background to the study; methodology; limitations and significance 
as well as; the outline of the study. The introduction gives background to the study by 
navigating the concepts and developments of food security to GMO, a component of the 
biotechnological industry, as an option in curbing food insecurity, its controversies, and 
challenges; before most importantly introduce the connection between GMO and Intellectual 
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Property; and finally, the synopsis and justification of the problem. The main objectives of the 
paper are also explained together with the Methodology and limitation of the study are then 
given, before an overview of the research is presented. 
The second chapter then centres on GMO regulations worldwide with the role Africa plays in 
the development of the law; the specific interventions towards Africa; and its impact on Africa 
as the underlining theme. It begins by looking at the major international treaties designed 
specifically or tangentially to address the issues and concerns of the GM industry. The 
Cartagena Protocol on Biosafety, TRIPS agreement which as the foremost IP treaty globally, 
UPOV Convention, as well as the ITCGR, will be assessed before the EU-US regimes for 
regulating GM. The bilateral and multilateral trade relations of countries in Africa and the rest 
of the world generate enormous benefits for all parties, how trade partners regulate GMOs is 
therefore imperative on any considerations the region contemplates.  
The effects these protocols and systems have on the continents food security are enormous, the 
continent’s affiliation with the EU and the US remain a significant policy determinant. While 
the United States considers GMOs as a significant element of the biotechnology industry, the 
EU has been quite cautious in wholly accepting GM. Agriculture in Africa is not only for 
consumption but also a means of livelihood support, the effect of the seemingly divergent 
approach by the African countries’ significant partners and donors amid their respective 
positions and international treaties create a quagmire that needs to be navigated. Regulatory 
issues like labelling, acceptability and trust are also considered under this chapter. 
With the divide on the acceptability of GMOs in Africa on going, the need to craft IP protection 
for GMOs that are responsive to both the demands of the region and the positioning of other 
IP regimes becomes imperative. Chapter Three, therefore, makes an inquiry based on the 
fundamental question of how has and should GMOs be protected in general and Africa in 
particular? Plants, animals, microorganisms and other organisms with modified genetic 
makeup via genetic engineering or transgenic technology are all included under GM, and they 
differ from plant varieties. Plant varieties are obtained from natural biological processes; 
however, due to technological advancements, it is difficult to distinguish between the two. The 
rift between patent and sui-generis protection is manifested in the European scenario, but are 
they the only rights to be considered under the circumstances? The issues of ownership and 
control, liability and intent, infringement, biopiracy, GURTs amongst others are very crucial, 
and a significant consideration in the type of protection.  
11 
 
The protocols that regulate GMOs internationally impact policies within the continent on 
several counts; however, the role Intellectual Property plays in terms of food and genetic 
resources is of paramount concern in this research. Chapter four focuses on access, and begins 
by looking at what access is within the context of the law, access to food is considered as a 
human right issue but is it a sufficient ground to break IPR? Foreign IPR holders dominate the 
current system. The compass is, therefore, on how countries can access protected GM 
materials, that is, the flexibilities within the law, by which policies can be fashioned out, albeit 
dependent on the type of protection. The actual implementations of the flexibilities for access 
are assessed to see how countries have indeed utilised the spaces given through their 
incorporation of treaty obligations in national laws. And then finally we look at other 
alternatives proposed for the facilitation of access to food  
Chapter five concludes on food security; that is how the observations in this paper affect food 
security in Africa. It summarises the comments within the paper and makes recommendations 
for public policymakers, rightsholders, farmers, and the general populace on the IP aspects of 
GMO and how it can influence access to food. The table in chapter 2 shows the number of 
treaties that each African country is a party to. 
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Regulating GM’s across territories: it is through the law, that GMOs come to exist in the 
particular way they do in the world. 
2.0 REGULATING GENETIC MODIFICATION 
As a developing field, Genetically Modified Organisms are regulated differently across the 
globe; from their inception in the laboratory through to their use by consumers, a genetically 
modified plant undergoes different restrictions and approvals processes. There are not just 
different rules for different types of GMOs; different rules applies to GM that humans eat and 
for animal feed. GM regulations also vary as much between treaties as amongst national 
legislations. A genetically modified plant may, for example, be sanctioned for general use in 
the United States, but only as feed for animals by member states of the EU, or may not be 
sanctioned for any in Japan.24 Even though the politics of regulating the risks of GMOs remain 
an active and incomplete project, the intersection of GMOs and the different fields of law, in 
particular, Intellectual property, have evolved into one rich area of research. 
In this chapter, the treaties and legislation that governs GM are the point of focus, with 
particular emphasis on IP treaties related to GM. We look at how different jurisdictions have 
and continue to regulate GM foods and their Intellectual property outlook. This is done by 
assessing the regulatory frameworks that govern GM; how they came about; what treaties apply 
in certain countries; their potential effects, and the Intellectual Property clauses. The 
contributions of Africa, the specific interventions aimed at Africa and the general outcomes 
regulating GM as well as, sections of the law relating to the transfer and exchange of resources 
are all considered since food security goes beyond access to food.  
Internationally, GM features in many treaties and agreements, whiles the Convention of 
Biological Diversity’s (CBD) Cartagena Protocol Biodiversity (CPB) looks at the transfer of 
GM, the Sanitary and Phytosanitary Measures (SPS Agreement) that the WTO oversees 
focuses on trading GMO internationally. Other agreements such as the TRIPS, the FAO’s 
ITGRC, and UPOV of WIPO also play vital roles in shaping the regulatory framework of GMs. 
Each treaty has its aims and objectives and may sometimes relate differently to similar 
situations. Regions like EU, US, and developing countries have also been approaching GM 
 
24 Holm, S. (2015). When They Don't Want Your Corn: The Most Effective Tort Claims for Plaintiffs Harmed by 
Seed Companies Whose Genetically Engineered Seeds Produced More Problems Than Profits. Hamline L. 
Rev., 38, 557. 
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regulations differently. The United States and the European Union, for example, have a shared 
interest of providing healthy foods and a reliable regime of regulation, yet, each has chosen 
different paths when it comes to the surge in GM food and feeds for animals available.  Other 
countries, mostly developing ones, are also in the formative phase when it comes to GM 
regulation, with a number of them inching toward the middle of the US EU ends.25 
Again, IP has in recent times been one primary consideration in the GM regulation discuss, as 
such, the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement by has been 
a crucial instrument for GM regulations. We start by looking at some international treaties, 
before looking at the US and EU, since in their efforts to design a responsive system for 
regulating biotechnology, many of the countries in Africa come up against the might and 
influence of both the US and the European Community aside treaty obligations.  After which 
the various regulatory issues such as the institutions and capacities they required, Trust and 
Acceptability, traceability and labelling are also considered within the policy space left for 
nations. The traceability and labelling requirements, for instance, have forced a number of 
developing countries to refrain from GM crops, this is because they fear to lose the European 
Community markets over issues such as improper segregation of GM and non-GM products. 
 
2.1 INTERNATIONAL TREATIES (CBD/CPB: TRIPS: ITGRC, UPOV) 
2.1.1 The Convention on Biological Diversity (CBD): The Cartagena Protocol on 
Biodiversity (CPB).  
Genetic Modification as a subset of the biotech industry since its introduction in the 1990s has 
been regulated at the International level by different instruments. These regulations have 
undergone several phases, but to date, The Cartagena Protocol on Biosafety (CPB), remains 
the sole international regulatory protocol that was specifically created to forestall the risks 
biotechnology has on biological diversity.26 It is one of the significant protocols under the 
Convention on Biological Diversity established by the UN.27 The CPB seeks to regulate the 
 
25 Patterson, L. A., & Josling, T. (2002). Regulating biotechnology: comparing EU and US 
approaches. Environmental policy in the European Union, 183-200. 
26 The CBD has various sub-programs and agreement: Cartagena Protocol on Biodiversity; Global Strategy for 
Plant Conservation: Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits 
arising from their utilization 
27 On 29 January 2000, the Conference of the Parties to the Convention on Biological Diversity adopted a 
supplementary agreement to the Convention known as the Cartagena Protocol on Biosafety. It is a legally binding 
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supervision, usage and movement “living modified organisms” (LMOs) in the way that restricts 
the possible adverse effects on biodiversity. The potential risks posed by LMOs are to be 
controlled with the creation of an advance informed agreement (AIA) procedure.28 
The CPB generally governs how GMOs are transported across borders, the safety measures 
needed, and grounds on which governments should decide on whether or not to allow GM into 
their countries. It concedes that biodiversity goes beyond plants, animals, and microorganisms 
and their ecological community. The CPB prioritises people and the necessities of life like 
food, shelter, medicines, and activities that pollute the environment.29 Most African states are 
among the 193 countries that are parties to the CPB, and therefore, only allowed to develop 
laws stricter than those set out in the CPB. The Precautionary Principle (PP) which underlines 
the convention stems from the declaration’s demand for a halt or suspension on approvals in 
order to prevent environmental degradation in areas where the possibility of severe or 
permanent damage is likely, even if scientific data is inconclusive.30 It is on this premise that 
other international regimes concerning GMOs and several African states argue. And many of 
the countries that are sceptical about GMOs justify their slowness in accepting GMOs into their 
markets when the health uncertainties and environmental concerns cannot be entirely dismissed 
on this principle. The GM industry, however, claims that rejecting GMOs without sound 
scientific proof of proven harm is unreasonable. 
Sections such as article 20(4) emphasis the extent to which developing country implementing 
their commitments under this Convention is incumbent on developed country parties fulfilling 
their obligations. Obligations relating to financial resources and transfer of technology, 
economic and social development, as well as the eradication of poverty, are the primary and 
overriding priorities of the developing nations/parties. Even though Intellectual property 
interests were not a non-negotiable issue when the CBD’s was being formed, the treaty by its 
nature and the aftermath implementation has evoked severe IPRs concerns. Helfer (2004) 
argued that “a careful examination of the CBD shows that any intellectual property rights 
 
convention that recognizes the conservation of biological diversity is a common concern of humankind and is an 
integral part of development process. It covers all species, ecosystem, genetic resources. 
28 This procedure ensures that countries are provided with the information necessary to make informed decisions 
before agreeing to the importation of each organism into their territory. 
29 CBD, About the CBD, available at http://www.biodiv.org/convention/default.shtml 
30 U.N. Conference on Environment and Development, June 3–14, 1992, Rio Declaration on Environment and 
Development, at 6, U.N. Doc. A/CONF.151/26/Rev. 1 (Jan. 1, 1993). See Commisión Nacional de Recursos 
Fitogenéticos, Frequently Asked Questions About the Cartagena Protocol on Biosafety, 
http://www.conarefi.ucr.ac.cr/Bioseguridad1.htm 
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system that is at variance with the CBD’s objectives should be must be accordingly be 
adjusted.”31 The convention also incorporates the importance of protecting third-party and 
society interest when protecting inventions in plant materials, especially with the proliferation 
of IP rights, biopiracy, and commercial realities. As a result, some countries especially 
developing ones, have tried to use CBD structures to harmonise their intellectual property 
systems. 
Even though the importance of biodiversity and EU legal rules in protecting it was underlined 
in case C-59/11 Association Kokopelli v Graines Baumaux SAS EU where the advocate 
general raised the  EU obligations under the CBD,32 the CPB seems to focus on the adverse 
effects that LMOs potentially pose to the environment, and the destruction to biodiversity as 
the commercialisation and utilisation of Genetic Resources are held mainly by private entities, 
at the expense of facilitating the technology transfers that developing countries were 
promised.33  
2.1.2 Trade-Related Aspects of Intellectual Property Rights (TRIPS) 
The World Trade Organization (WTO) emerged as the governing body for global trade from 
1995 and has approached GMOs as a trade issue rather than a safety one. However, its Sanitary 
and Phytosanitary (SPS) Agreement guides the health and safety of GMO. Contrary to the 
CBD, the SPS demands that risk assessments results from the most current science should be 
the basis for decisions. The Agreement delineates measures that members should use in 
protecting and safeguarding the health of people, animal, and plant life. These measures include 
risks associated with the additives and contaminants that are used in food as well as the impact 
that the entry or spread of pests, and either disease-carrying or causing organisms have in 
general.34 
The core aim of the SPS Agreement is to stop countries from creating measures that are 
protectionist in nature under the pretence of health and safety. Thus, the agreement streamlines 
health and safety standards across the board and requires members who adopt higher protective 
 
31 Helfer R. L, (2004), Regime Shifting: The TRIPS Agreement and New Dynamics of International Intellectual 
Property Lawmaking, 29 YALE J. INT’L L. 1, 24, n.10.  
32 Association Kokopelli v Graines Baumaux SAS EU.  C2012;447 
33 Lawson C, 2012, Regulating Genetic Resources: Access and Benefit-sharing in International Law (Edward 
Elgar). 
34 Gonzalez, C. G. (2006). Genetically modified organisms and justice: the international environmental justice 
implications of biotechnology. Geo. Int'l Envtl. L. Rev., 19, 583. 
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measures to justify their decision scientific evidence. Accordingly, and contrary to the CDB 
precautionary principle, GMOs, are not be rejected without solid scientific reasoning. 
Moreover, the WTO’s agreement on Technical Barriers to Trade also prohibits the rejection of 
GMOs without any scientific proof of harm.35 Countries like USA, Canada and Argentina in 
the past instituted actions against the European Union under the SPS when some EU member 
states banned particular GMOs because they thought they were unsafe. And the WTO ruled 
that the scientifically adduced evidence of harm was lacking; therefore, the ban was not 
justified.36 
Trade-Related Intellectual Property Rights (TRIPS) is another critical agreement the WTO 
have that is currently affecting GM hugely.37 TRIPS have upon its inception been either an 
inescapable consideration for or the bedrock upon which several other treaties and legislations 
hinges on and its clauses affects the biotech industry significantly. Although Trips is an 
agreement on the IP aspects of trade and not directly a GM regulation, it is one agreement that 
has a far-reaching impact on GM and plant varieties. The Trips agreement has been a tool for 
shaping the biotech and for the matter the GM industry.38 
Before TRIPS, the Paris Convention, which came about in 1883, was the most accessible 
intellectual property accord that nations subscribed to. The convention relied on the principle 
of national treatment, as it did not have uniform standards for protecting intellectual property 
rights.  National treatment meant that both goods of home and foreign applications are given 
the same, and one is not discriminated against the other. However, each country was allowed 
to set its intellectual property system. Later the Patent Cooperation Treaty was concluded in 
1970 to augment the Paris Convention, and it introduced a centralised process for all 
application on utility patent.39 
 
35 Löfstedt, R. E., Fischhoff, B., & Fischhoff, I. R. (2002). Precautionary principles: General definitions and 
specific applications to genetically modified organisms. Journal of Policy Analysis and Management: The Journal 
of the Association for Public Policy Analysis and Management, 21(3), 381-407. 
36 International law governing GMOs. http://safsc.org.za/wp-content/uploads/2015/09/int-law-governing-SA-
GMO.pdf 
37 Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), a treaty that is generally 
recognized as the most robust embodiment of intellectual property rights was enacted in 1994. 
38 the vigorous efforts and pressure of Biotechnology companies for recognition and enforcement of the rights to 
their seeds in the international community, securing intellectual property protection for its agricultural industry 
was a major goal of the United States during the TRIPS negotiation 
39Kawamura, S. (2011). GMO trade in the context of TRIPS: From the perspective of an autopoietic system 
analysis. Ritsumeikan Journal of International Affairs, 10, 243-268. 
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However, intending to promote and facilitate international trade, TRIPS sets out general 
principles and minimum standards which are binding on all its members. It's negotiators also 
consciously left room for manoeuvre so that governments can accustom domestic IP laws and 
policies to safeguard critical national interests. Member countries have to enact the necessary 
legal framework that includes the set minimum regulations. These standards include, amongst 
others, a minimum patent period of 20 years; provision for product patents; and the protection 
to [pharmaceutical] test data from ‘unfair commercial use’. Members are further compelled to 
protect plant varieties either by patents, an effective sui generis system or by any combination. 
The patent articles set “any inventions, whether products or processes, in all fields of 
technology, provided that they are new, involve an inventive step and are capable of industrial 
application” as patentable subject matters.40 This provision expands the patent scope to include 
all aspects of the biotech industry. GMO’s requires at the very least some form of gene 
modification and TRIPS extends protection to genetic materials that have been modified at the 
cellular level, but not to the whole genetically modified plant.41  
TRIPs also categorise nations according to their stage of developments. Most of the countries 
in Africa are either developing or least developed that had to commit to protecting and 
enforcing IP rights before they will be admitted by the convention and by extension, global 
trade. 42  This prerequisite was to insisted by developed countries as a way of protecting their 
domestic interests beyond their territories and in other countries. However, by 2015, 34 
disputes had cited the TRIPS Agreement, developing countries instituted 26 of those cases 
against developed, contrary to earlier predictions. Some developing countries have successfully 
gain access to agricultural and services markets in some developed countries through WTO 
disputes using TRIPS.43 
 
40 ANNEX 1C AGREEMENT ON TRADE-RELATED ASPECTS OF .... 
https://www.wto.org/english/docs_e/legal_e/27-trips.pdf. TRIPS’ recognizes is that living things may be 
patented; there is no general exclusion for microorganisms, and even developers of plant varieties (but not 
animals) must receive some sort of intellectual property protection for their “inventions.” it further demands that 
patent rights enjoyable without discrimination as to the place of invention, the field of technology and whether 
products are imported or locally produced.  
41 Kawamaru, S. Id  
42 Correa, C. (2007). Intellectual property in LDCs: Strategies for enhancing technology transfer and 
dissemination. Background Paper, (4). 
43 Report Changing the face of IP trade and Policy Making, 20 years of Trips 2015 
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So far, the impact of TRIPs in the biotech industry of countries in Africa has been enormous, 
particularly with the introduction of TRIP plus.44 Nonetheless, TRIPS is still considered by 
some critics as a breach of the ideals of many nations and been cited as the reason for some 
developing countries desiring to create their agreements that will be more responsive to their 
national interests and traditional practices.45 Most developed countries for decades had the 
opportunity to freely debated the need and how to protect plant material, without external 
pressures or influences, developing countries, on the contrary, have not had a history of 
debating this issue. Rather, all discussion has been limited to implementation within the context 
of the TRIPs agreement. Many countries in African are implementing TRIPs to the letter, but 
it is important to note that the likelihood of any intellectual property system that has not been 
redefined to accommodate the social, cultural and economic needs of the people succeeding is 
low.46  
2.1.3 The Union for the Protection of New Varieties of Plant Convention (UPOV) 
The UPOV Convention is another treaty that explicitly makes mention of the genetical 
modification/engineering of plant varieties and goes further in granting intellectual property 
rights for them.  The Convention was first introduced in 1967 but has undergone several 
changes, its latest act was in 1991, and it is this act that, as reflective of its era, acknowledges 
GM crops and the protection they need. UPOV’s latest changes acknowledged the dynamic 
nature of the biotechnology and Plant Variety industry and how they are affected by IP. Its 
plant protection system has been the alternative to patent that many countries have employed. 
UPOV’s membership comprises of both developed and developing nations. Currently, over 76 
countries worldwide are parties to the convention. South Africa, Egypt, Kenya and the ARIPO 
members are the countries in Africa that are officially are parties to the UPOV.47 However, the 
number of African countries that have their plant variety laws crafted as the UPOV model run 
 
44 The United States concerned that resort to this provision could weaken intellectual property rights of their 
biotech products, pressured developing countries into entering additional treaties, referred to as “TRIPS-plus” 
bilateral agreements. These “TRIPS-plus” agreements do not only contain more stringent intellectual property 
standards, but also enjoined developing countries to implement TRIPS more quickly than the specified transition 
periods, or require adherence to other multilateral intellectual property agreements. 
45 Kawamaru S. ib 
46 Gervais, D. J. (2001). The internationalization of intellectual property: new challenges from the very old and 
the very new. Fordham Intell. Prop. Media & Ent. LJ, 12, 929. 
47ARIPO members Benin, Burkina Faso, Cameroon, Cental African Republic, Shad, Comoros , Congo, Cote 
d’Ivoire, Equitorial Guinea, Gabon, Guinea, Guinea Bissau, Mali, Mauritania, Niger, Senegal, and Togo. 
https://www.upov.int/export/sites/upov/member/en/pdf/pub423.pdf 
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above the official figure. Some researchers, like Meienberg F (2015), have argued that UPOV 
negatively affects agriculture in developing countries.48 Plant variety protection, as expressed 
in the 1991 act, for example, impede farmers because it does not allow them to replant the 
seeds they have saved. Therefore, some countries like India will have lots of problems when 
they decide to join UPOV, especially with their active farmer’s rights. Kenya’s example also 
shows how UPOV is export-oriented since the majority of varieties are horticultural crops.  
  
2.2  REGIONAL REGULATORY SYSTEMS 
2.2.1  UNITED STATES 
In the United States, GM products are everywhere, as the majority of food products sold in the 
market contains gm. A 2007 study found that about 91% of all soybeans, 87% of cotton and 
73% of corn, for example, contained strains that were genetically modified.49 Even though 
some environmental hazards and human health risk issues continue to be raised, GM regulation 
is comparatively relaxed mainly because US government considers GM as an essential 
economic asset and the vibrancy of the biotech industry. The biotech companies wield 
enormous power that has been used to shape the law in their favour.50 
In general, regulatory approvals or licenses are needed before GMOs are cultivated, distributed, 
sold or consumed. Crops are grouped into several categories, and this determines how they are 
regulated and the type of license needed. Agricultural plants, for example, are classified under 
conventional, genetically modified, organic and the combinations thereof such as conventional 
plants that are not genetically engineered, conventional crops that are genetically engineered; 
or purely organic.51 In addition, genetically engineered crops are further divided based on what 
 
48 Correa, C. M., Shashikant, S., & Meienberg, F. (2015). Plant variety protection in developing 
countries: A tool for designing a sui generis plant variety protection system: An alternative to UPOV 
1991. By: Association for Plant Breeding for the benefit of society (APBREBES) and its member 
organizations: Berne declaration, the development fund, SEARICE and third world network. 
49 ibid 
50 Strauss, D. M. (2009). The application of TRIPS to GMOs: international intellectual property rights and 
biotechnology. Stan. J. Int'l L., 45, 287. 
51 Holm S. (2015) "When They Don't Want Your Corn: The Most Effective Tort Claims for Plaintiffs Harmed by 
Seed Companies Whose Genetically Engineered Seeds Produced More Problems Than Profits," Hamline Law 
Review: Vol. 38: Iss. 3, Article 6. Available at: http://digitalcommons.hamline.edu/hlr/vol38/iss3/6 
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they are being used for (food, feed, ethanol), whether they can be exported to certain countries 
and the purpose of use (experiment). A gm technology can also be approved for no use at all.52 
Currently, the United States Department of Agric. USDA, Environmental Protection Agency 
(EPA), Animal and Plant Health Inspection Service (APHIS), and the Food and Drugs 
Administration FDA, are the four central institutions that regulate the GM and biotech industry. 
The intended use generally determines the supervisory agency.53 The FDA, for example, 
regulates GMOs that are used in food, while the EPA responsible for the effect of GMO used 
as pesticides on the environment, using the Federal Insecticide, Fungicide, and Rodenticide 
Act. The USDA also regulates plant pests and noxious weeds through the Plant Protection Act.  
GM may be released in so far as they meet some six primary criteria are met. The criteria first 
require that plant species are determined and that the transgenes must be stable and capable of 
being integrated. The function of the transgenes must also be known and must not result in the 
production of an infectious substance like a virus. Furthermore, any introduced sequence that 
is derived from plant viruses must pose the risk of creating new plant viruses. And finally, the 
plant must not contain genetic material derived from an animal or human pathogen. Producers 
are currently not required to label GM food in the US, but National Bioengineered Food 
Disclosure Standard (2016) law which comes into effect from 2020 will make it mandatory for 
companies to put a text on the packaging, a symbol or an electronic link that shows that the 
product or part of it is biologically engineered 
Within the United States, patenting genetic modifications are not only allowed but actively 
encouraged. This is because judicial pronouncements, legislative acts and policy initiatives 
over the last five decades have thoroughly changed the jurisprudence of IP in the biotech sector. 
These changes have allowed genetically modified organisms and plant genetic resources to be 
protected as under patents and at the same time strengthening other sui generis intellectual 
property regimes such as PBRs. Consequently, the number of patents for agricultural biotech 
has risen exponentially.54 Interestingly the US holds a number of patents in joint ventures, but 
 
52 ibid 
53 Sec Coordinated Framework for Regulation of Biotechnology, 51 Fed. Reg. 23,302. 
 54 Under plant technology, a total of 2,976 patents was awarded as of 2000.68% of which occurred in the most 
recent four-year period.12 Similarly, 66% of the 4,129 total patents for genetic transformations were awarded 
between 1996 and 2000.13 Out of all U.S. agricultural biotechnology patents awarded, most have been awarded 
to U.S. firms (4,331), followed by non-U.S. firms (3,051) and U.S. nonprofits (2,344). 
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private companies hold the bulk of patents. Monsanto, for instance, currently owns or licenses 
more than 90% of the genetically modified seeds globally.55 
Internationally, the US, as a champion of granting IP for GM and a global leader in the GM 
industry, continually seeks to export its standards to other areas with no exception to Africa. 
Their biotech industry is believed to be the main force behind the TRIPS agreement, but the 
evolving nature of the industry due to new developments resulting from new laws and court 
decisions needs to be internationalised as well.56  And this being done through trade agreements 
that aim to synchronise other practices with US standards. The African Growth and 
Opportunities Act (AGOA) of 2000 is one free trade agreement that hugely impacts GM 
regulations.57  
2.2.2  GMOs AND THE EUROPEAN UNION 
Unlike the US, the growth of Genetically Modifications and plant genetic industry across 
Europe has been relatively steady as the marketing and cultivation of GM seeds have been low. 
Currently, less than 1% of arable lands are under GMO cultivation even though the EU allows 
it. However, considerable amounts of GM products like maize and soybeans are imported and 
used mostly as animal feed within the EU.58 The European Union have been very conservative 
in its approach to regulating GMOs mainly to public perception reasons.25 Notwithstanding, in 
order to ensure that GM takes place in safe conditions, the European Union has set up a legal 
framework consisting of a number of directives, regulations and institutions to oversee the 
modern biotechnology industry and its advancement.  
The framework aims to regulate GMOs in Europe by protecting not only human and animal 
health but the environment as well. It introduces high safety assessments standards for any 
GMOs introduced on the market by establishing harmonised procedures that are efficient, fast 
and transparent for the risk assessment and authorisation. The Union have so far been 
 
55 Rifkin J. (1998) HARNESSING THE GENE AND REMAKING THE WORLD: THE BIOTECH CENTURY 
68 (describing the seed industry as a global $15 billion industry). 
56 Their influence on the biotech industry has not only stemmed from their political position but their market share 
of the GM industry. 
57 Formally known as the Trade and Development Act of 2000, AGOA is a unilateral extension of market access 
by the United States of America (US) to chosen sub-Saharan Africa countries. It commits 41 African countries to 
take particular positions in support of the US at the multilateral trade level. The 41 countries were chosen 
according to eligibility criteria under section 104 of the Act. 
58 In 2015 only one GMO variety, the MON 810, was cultivated in Europe and only 40 GMO based products were 
imported mainly for animal feed (soya) 
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employing the precautionary principle through market authorisation requirements and 
environmental assessment conditions to restrict GM. The WTO expert panels decision in 2006, 
for example, showed how widespread moratoriums on approval and marketing of GMO foods 
were used between 1999 and 2004.59  
Member states have the autonomy in allowing the GMOs cultivation within their borders, and 
can, therefore, restrict or ban GM cultivation if their socio-economic impacts on agricultural 
practices and others are harmful. Although before 2015, only health reasons had been cited for 
restrictions.60 They can also consign the cultivation of GMOs to demarcated areas within their 
territories, but the conversation on whether a Member State can ban its sale and use entirely 
threatens the free movement of goods across the EU’s internal borders.61 If a Member State 
elects to grow gm, it is up to that state to decide if it will allow GM crops to be planted along-
side non-GM crops determine the distances between them; currently, they vary from 5 to 600 
meters.62  
European Commission and the European Food and Safety Authority are the central bodies 
responsible for GMO regulations.63 The EC deals with the drafting of proposals for granting or 
refusing authorisation,64 while the EFSA preoccupies itself with the Scientific assessment 
conducted on public health and other scientific considerations. EFSA examines emerging 
issues and new hazards by updating assessment methods and approaches.65 The EFSA also 
conduct extensive, case-by-case, science-based food evaluation in order to respond to enquiries 
from the other EU institutions and the Member States in a manner backed by sound science.  
 
59 In 2006, the WTO dispute settlement panel issued its final decision (the EC-Biotech decision) in the complaint 
brought by the United States, Canada, and Argentina against the European Communities (EC) over the EC’s 
alleged moratorium on the approval and marketing of agricultural and food products containing genetically 
modified organisms (GMOs) findings determined that the EC’s moratorium was against Annex C(1)(a) and 
Article 8 of the SPS Agreement, which prohibit “undue delay” in product approval procedures. 
60 Hartung, U., & Schaub, S. (2018). The Regulation of Genetically Modified Organisms on a Local 
Level: Exploring the Determinants of Cultivation Bans. Sustainability, 10(10), 3392. 
61 Directive (EU) 2015/412 of the European Parliament and of the Council of 11 March 2015 amending Directive 
2001/18/EC as regards the possibility for the Member States to restrict or prohibit the cultivation of genetically 
modified organisms (GMOs) in their territory. https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=OJ:JOL_2015_068_R_0001 
62 Pearce, B., Woodward, L., & Sanders, R. (2006). Engineering Coexistence. 
63 Brussels, 07.10.2002 COM(2002) 545 final REPORT FROM THE COMMISSION TO THE EUROPEAN 
PARLIAMENT AND THE COUNCIL Development and implications of patent law in the field of biotechnology 
and genetic engineering 
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2002/0545/COM
_COM(2002)0545_EN.pdf 
64 Davison, J. (2010). GM plants: science, politics and EC regulations. Plant Science, 178(2), 94-98. 
65 How the EFSA works, https://www.efsa.europa.eu/en/about/howwework 
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The Legal protection of Biotech inventions is mainly guaranteed under Directive 98/44/EC, the 
European Patent Convention and other legislation like Directive 2009/41/EC which deals with 
the contained use of GM micro-organisms and Regulation (EC) 1946/2003 which concerns the 
transboundary movements of GMOs. Directive 2001/18/EC also regulates how GMOs are 
dispersed into the environment while Regulation (EC) 1829/2003 governs genetically modified 
food and feed. However, to ensure that consumers and other interests make informed choices, 
the traceability and labelling rules for food and feed that GMOs are managed by Regulation 
(EC) 1830/2003. This regulation stipulates that every GMO must be labelled except when its 
GMO content is beneath 0.9%.66 In addition, the Commission Implementing Decision (EU) 
2018/1790 repealing Decision 2002/623/EC67 has repealed the Guidance Notes of 2002,68 but 
with regards to the Environmental Risk Assessment (ERA) of genetically modified organisms, 
the Commission Directive (EU) 2018/350 has amended Directive 2001/18/EC,69 in order to 
ensure that ERA requirements are keeping up with scientific developments and technical 
progress.  
Recent studies have shown that although this framework comes at severe costs, its impact on 
other regions of the world is equally immense. The EU’s internal and external rule-making 
affects its trade partners. The EU uses bilateral trade agreements (BTA) and some of its internal 
legislation as a mechanism to influence developments in developing countries and other 
multilateral agreement.70  For instances, several researchers have observed that developing 
countries ability to utilise the flexibilities in TRIPS, is severely hampered by other trade 
agreements. The EU, in particular, has an Economic Partnership Agreement with Africa, in 
which stricter and enhanced IP updates that may not necessarily be conducive for promoting 
access to food, medicines, and development, in general, are drafted for African nations to 
 
66 GMO legislation - Food Safety - European Commission. https://ec.europa.eu/food/plant/gmo/legislation_en 
67 : Publication of Commission Implementing Decision (EU) 2018/1790 of 16 November 2018, repealing Decision 
2002/623/EC, establishing guidance notes on the environmental risk assessment of genetically modified 
organisms. 
68 To reduces the number of guidance documents that operators and competent authorities need to take into 
account, when carrying out an environmental risk assessment under Annex II to Directive 2001/18/EC. 
69 Publication of Commission Directive (EU) 2018/350 of 8 March 2018 amending Directive 2001/18/EC, 
concerning the environmental risk assessment (ERA) of GMOs. 
70 Acquah, D. O. (2017). Intellectual Property, Developing Countries and the Law and Policy of the European 
Union: Towards Postcolonial Control of Development. (page 48) argued that How they negatively affect access. 
He uses the Common Commercial Policy analyse expansion in Trips, the redesign in EU trade policy. Customs 
regulation, does the updated regulation appropriately ensure balance in Access. 
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consider in addition to, the developments from CJEU. Most of which has not been favourable 
for Africa.71  
So far, some African countries are parties to the EPA, and much of Africa's agricultural produce 
is still destined for Europe markets. The refusal of many African countries in taking the UN 
“aid” in 2007 for example, was not only due to the potential effect GMO had on human health 
and environmental but also the EU’s attitude towards GMOs and food safety rules.72 
 
2.2.3  AFRICA 
Since regulations of Genetically Modification started in the 1990s, many countries have gone 
through the process of formation, gradual modification, and evolution of their rules; however, 
with the exception of some few countries in Africa, the majority seem to still be at the formation 
stages even though GM crops are being cultivated, consumed, and traded in large quantities 
within their territories and on the international markets.73 While the majority of nations are 
silent of the subject, South Africa, Burkina Faso and Sudan are the main countries that are 
commercially exploring GMO even though a number of other countries like Algeria outrightly 
bans GMOs within their territories.   
The Africa Union, as a supranational body is yet to implement a protocol that comprehensively 
addresses GM in general nor GM-IP in spite of its resolve in its 2006 Decision 
EX.CL/Dec.26(III) to have a common stand on modern biotechnology. The decision 
acknowledged that biotechnology could help increase production, yet opposing views have 
delayed the assessment and adoption of GM technologies for this purpose. The absence of a 
clear path from the AU has led to two things happening; first, nations having to fall on bilateral 
and multilateral agreements like sub-regional directives, other trade agreements and 
international treaties for direction. Second, GM companies having had to employ stringent 
 
71The CJEU in 2001 ruled that there is no provision in the CBD which requires that the conditions for the grant of 
a patent for biotechnological inventions should include the consideration of the interests of the country from which 
the genetic resource originates or the existence of measures for transferring technology and that by virtue of Article 
1(2) of Directive 98/44/EC, the Member States are required to apply the Directive in accordance with the 
obligations they have undertaken as regards biological diversity 
72 Strauss, D. M. (2008). Feast or famine: the impact of the WTO decision favoring the US biotechnology industry 
in the EU ban of genetically modified foods. Am. Bus. LJ, 45, 775. 
73 Crops like maize, cotton, cassava are some of the gm variety grown and in which countries Burkina Faso, Egypt, 
South Africa, and Sudan, the rest have been slow in adopting GM for various reasons, trade, health, regulation. 
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measures like licensing and GURT to ensure the protection of their products. Both effects 
impact severely on food security within the region. The African Free Trade Agreement which 
recently came into force, however, directs AU minister to submit for adoption a draft that detail 
among other the continent’s policy for Competition, Investment, and Intellectual Property 
Rights.74  
Many African nations are part of international treaties either individually or as a block. About 
52 of the 54 countries parties to the TRIPS agreement and over 40 African countries are also 
parties the Cartagena Protocol on Biosafety and its mother convention the CBD which regulates 
the cross-border movement of GMOs. The Treaty on Plant Genetic Resources for Food and 
Agriculture (ITPGRFA), and the UPOV are some of the other treaties that many African 
countries are parties to. These treaties provide broad guidelines that often require specific 
structures and institutions to oversee implementation. Most of the countries in Africa are 
nonetheless still developing the needed structures and institutions while the few others that 
have managed to set up the structures required are non-functioning therefore unable to access 
the full complement or benefits from these treaties. 
Other sub-regional bodies in Africa like SADC, ECOWAS, COMESA, EAC also exist within 
the continent.75 None of these regional groupings has enacted any comprehensive policy on 
GM yet, but they seem to be more ahead in the process of securing one than the AU. ECOWAS, 
for example, has an Action plan that aims to check biotechnology and biosafety developments 
for its members.76 The plan resolved to expand productivity to levels that genuinely affects the 
development process by expanding the market for agricultural products in West Africa. It 
sought to promote the regional markets and the integration of the West African agriculture into 
the global market via the strengthening of regulatory systems and a product quality approach; 
Elimination of trade barriers; Resolution of the intellectual property issues to promote 
technological development while taking the many socio-economic contexts and roles of 
agriculture into account. The action plan beheld member states to avoid being in contradiction 
 
74 ASSEMBLY OF THE UNION Tenth Extraordinary Session 21 March .... 
https://au.int/sites/default/files/decisions/34055-ext_assembly_dec_1x_e26_march.pdf 
75 The major African regions developed guidelines and policies to move the process forward. 
SADC established an advisory committee in 2003 to focus on handling of food aid, policies and regulations, 
capacity building, and public awareness. However, this committee seems to have been dormant for the past several 
years. 
The AU policy guidelines attempt to guide member states in establishing public awareness, biosafety strategy, 
harmonization, participation in international negotiations, and stakeholder collaboration. 
76 During the ministers meeting of ECOWAS in 2007 action plan 
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with the international agreements in other to benefit from the GMOs by adapting their national 
legislation with the help of the African Intellectual Property Office.77  
Notwithstanding the delay of the regional and continental bodies, some individual nations 
within Africa have been formulating some policies on GMs. Mauritius, for example, enacted a 
GMO act in 2004. South Africa, being the most vibrant GMO nation in Africa, also has a GMO 
law. The Mauritius act, however, applies to recombinant nucleic acid techniques that create 
new combinations of genetic material; methods that introduce alien nucleic acid molecules into 
an organism of; or cell fusion likes protoplasts, beyond the same taxonomy.  Hybridisation 
techniques that form live cells with the new genetic material combination are also considered 
under the act but overlook genetic manipulation of human cells or processes that do not use 
recombinant nucleic acid molecules or genetical modifications. 78  
On the other hand, Algeria, Rwanda and Madagascar amongst many others have bans in place 
for GM crops. 79 But given the homogeneity of the region, the effect is that the continent stands 
the risk of an unharmonised policy on GM and the issues thereof. A harmonised regulation that 
synchronizes the approval system at the regional level and addresses the fragmentation in 
approaches may be needed to improve access to GM food.  
2.3. REGULATORY ISSUES 
By creating crops with higher yields, better nutritional value and stronger resistivity to disease, 
GMs have the potential of improving food security, reducing malnutrition and fighting poverty, 
but as to whether GM can provide meals that are accepted by all is the question. Many people 
within the African continent are hungry, but the food provided must be acceptable. Unlike the 
EU and far from the US, the attitude of Africans towards GM has not been entirely responsive, 
and a sizeable number are still sceptical about GM for many reasons. The fear of the unknown 
has been one big reason some researchers assign to this phenomenon.  
 
77 Action 3.2.2.1.1.10: To strengthen existing IP systems in the Member States. Since the ECOWAS countries also 
belong to the African Intellectual Property Organization (AIPO), the national representations of these 
organizations should be mobilized by ECOWAS with a view to not only re-examining the national legislation in 
order to adapt them to the new global context, but also assist the countries in setting up the administrative and 
technical institutions in charge of intellectual property issues. 
78 Section 6(3) of the Mauritius GMO act. 
79 Food Related Regulation in Africa Compared to EU and US .... https://www.waystocap.com/blog/food-related-
regulation-in-africa-compared-to-eu-and-us/ 
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GM is a relatively new development; thus, most of the long-term effects are still unknown. 
However, the direct and indirect socio-economic and ecological consequences of GM often 
contemplated largely accounts for the seeming lack of trust. This notion has been long sustained 
because many of the African households are small-scale farmers who rely on natural resources, 
and uncomfortable with farming inputs/practices that increase the vulnerability of its 
biodiversity.80 Although nations have different peculiarities, the adverse reports in other 
country are often exaggerated. The possibility of contamination for endemic or staple food 
crops gene pools, for example, was not only crucial in South Africa’s rejection of research 
applications on genetically engineered cassava and sorghum, but also the basis debates in other 
countries. Clapp, J. (2005) also observed that the European rejection of genetically engineered 
food had made Europe destined exporters who are in the majority in many African countries 
cautious in adopting GMOs.81  
Several actors from different quarters have espoused many suggestions regarding ways of 
improving trust and acceptability of GM in Africa. But institutional capacity is one defining 
measure. Since profit-driven private entities and not governments and agents responsible for 
ensuring food security, are directing GM research,  the unrest among farmers and consumers 
are high, because the supervising institutions are inadequate and non-performing. Research 
shows that both developers and consumers of GM are in many ways comfortable when there 
are institutions that guarantee the protection of developers’ interest on one hand and consumer 
protection on the other. It is not surprising then that most treaties require the establishment of 
specific institutions and capacity. 
While some treaties may be vague as to the composition and capacity of these institutions, 
others demand strict compliance. The institutions mostly define the parameters, specify or test 
gm, decide on disputes, among others within the sector. Many of the GM treaties require the 
setting up of specific institutions. The CPB requires parties to publish all their decisions on 
GMOs, on an international website called the Biosafety Clearing-House (BCH) as well as 
summaries of the scientific safety studies carried out on these GMOs. This information is vital 
as it informs citizens, governments and industry about decision making on GMOs. This 
 
80 Moola, S., & Munnik, V. (2007). GMOs in Africa: food and agriculture. Retrieved March, 25, 2012. 
81 Clapp, J., 2005. The political economy of food aid in an era of agricultural biotechnology. Global Governance 
11: 467-485. 
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mechanism helps the public to understand what GMOs are and also encourage public 
participation and scrutiny.  
So far, a number of African countries are in the process of setting up the required institutions, 
while the others that already have laws that make provision for seed testing stations like Zambia 
Sudan and Botswana are acquiring some kits to boost their capacity for the GM industry. South 
Africa, for instance, was able to reject Syngenta’s application to import GM maize for ethanol 
on the grounds of food safety because it had the necessary facility to assess. The African Centre 
for Technology Studies (ACTS) also coordinated a study that assessed the current IPR practices 
in select African countries and identified the capacity of institutions in carrying out policy 
dictates and even simple documentations as a major challenge although the majority of the 
countries have IP laws.  
The effects of many regulations in Africa have been low due to defects in the administrative 
structure needed for implementation and enforcement.82 Several studies have also observed 
that most of the institutions are either non-existent or ill-equipped to carry out their mandate. 
Some noticed that many national patent offices in Africa, in particular, were inadequately 
equipped to perform their core functions of examining patent applications and compiling data 
on patents for the public and other inventors. This, in effect, is facilitating the exploitation of 
essential genetic resources by foreigners who are protecting ideas and discoveries that are not 
patentable. 83 While investigating the South African patent system, Pouris (2011) argued that 
‘granting patents for inventions that are not new or useful or that are obvious, unjustly rewards 
the patent holder at the expense of real inventors, the consumer and social welfare' when he 
was reviewing the patents system in South African. 84 
The example of European Patents Office revoking  Monsanto’s melon patent EP1962578, 
issued May 2011 which could potentially restrict access to all breeding material that have the 
virus resistance similar to the Indian melon is an indication that the need for not just institutions 
 
82 Mgbeoji P. (2009), Intellectual property rights in Africa: The way ahead. In Armstrong, D. (Ed.). 
(2009). Routledge handbook of international law. Routledge. 
83 Innovation & intellectual property: Collaborative dynamics in Africa EDITORS: Jeremy de Beer, Chris 
Armstrong, Chidi Oguamanam, Tobias Schonwetter ISBN: 9781919895994 (softcover) PUBLISHER: Open A-
I-R, UCT Press, Cape Town, ZAR350 (the electronic version is licensed under a Creative Commons license) 
PUBLISHED: 2014 
84 Pouris A, (2011) Patents and economic development in South Africa: Managing intellectual property rights. S 
Afr J Sci. 107(11/12):24-33. http://dx.doi.org/10.4102/sajs.v107i11/12.355    
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but ones that can examine patent claims and patents granted elsewhere.85 That is why it was 
refreshing when South Africa rejected the GM sorghum project on the basis that GM 
technologies that originate from Africa cannot be patented, and thereby setting limits even pro-
GM countries.86 
One major institution that needs to be equipped the most is the Court systems in Africa. That 
is a Judiciary system that will appropriately consider the continents peculiarities and give life 
to its laws is one element worth highlighting. USC has shaped the US system. The CJEU has 
made several profound judgments that have been telling on the gm industry, the decision on 
the presence of patented material alone without it performing stated function in Monsanto case 
has impacted profoundly even at the international level.  
Again, the different trade and regulatory directions that the United States and the EU are 
pursuing over GMOs is obscuring the conversation on the social, economic and environmental 
implications of GM technology in the developing world. The need to have a policy or at least 
a clear policy direction is crucial because of the different regulatory approaches by blocs such 
as the EU and the US; the tension should not sue Africa. The continent needs to fashion out a 
policy from the current policy space that will premiums the hard and pressing demands of 
Africa, such as access.  And also develop a consistent and coherent policy framework that is in 
line with the national developmental agenda — the needed expertise to press for more 
favourable terms while making the most out of the current system.  
But in conclusion, while a country-by-country report that provides comprehensively assess 
capacity of both research institutions and government departments responsible for 
implementing regulations on GMOs and to contribute meaningfully to discussions on the 
international stage is needed, the institutional and human resources to research and conduct 
policy analysis in IPRs available, the directions they are heading, and best practices all need to 
upgrade. 
 
 
 
 
85 Mgbeoji, I. (2007). TRIPS and TRIPS plus impacts in Africa. 
86 Africa Flak: Will GM foods keep a hungry continent better fed?. https://africaflak.blogspot.com/2008/03/will-
gm-foods-keep-hungry-continent.html 
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Table 1  
COUNTRY TRIPS CBD/CPB UPOV ITCGR 
Algeria  Observer X - X 
Angola X X - X 
Benin X X ARIPO X 
Botswana X X - - 
Burkina Faso X X ARIPO X 
Burundi X X - X 
Cabo Verde X X - X  
Cameroon X X ARIPO X 
Central African Republic X X ARIPO X 
Chad X X ARIPO X 
Comoros Observer X ARIPO - 
Congo, DR.  X X X X 
Congo, Republic Yes X ARIPO X 
Cote d’Ivoire Yes X ARIPO X 
Djibouti Yes X - X 
Egypt Yes X - X 
Equatorial Guinea Observer X ARIPO - 
Eritrea X X - X 
Eswatini (Swaziland) X X - X 
Ethiopia Observer X - X 
Gabon X X ARIPO X 
The Gambia Yes X - X 
Ghana Yes X - X 
Guinea Yes X ARIPO X 
Guinea-Bissau Yes - ARIPO X 
Kenya Yes X X X 
Lesotho Yes X - X 
Liberia Yes X - X 
Libya Observer X - X 
Madagascar Yes X - X 
Malawi Yes X - X 
Mali Yes X ARIPO X 
Mauritania Yes X ARIPO X 
Mauritius Yes X - X 
Morocco Yes X X X 
Mozambique Yes X - - 
Namibia Yes X - X 
Niger Yes X ARIPO X 
Nigeria Yes X - X 
Rwanda Yes X - X 
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Sao Tome and Principe Observer X - X 
Senegal X X ARIPO X 
Seychelles X X - X 
Sierra Leone X X - X 
Somalia Observer X - - 
South Africa X X X - 
South Sudan Observer X - - 
Sudan Observer X - X 
Tanzania X - - - 
Togo X X X X 
Tunisia X X X X 
Uganda X X - X 
Zambia X X - X 
Zimbabwe X X - X 
 
Source: Summary Table of Membership of the World Intellectual Property Organization 
(WIPO) and the Treaties Administered by WIPO, plus UPOV, WTO and UN 
https://www.wipo.int/treaties/en/summary.jsp   
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IPRs, the new battleground for the GM and biotech industry  
3.0.  THE INTERSECTION BETWEEN GENETIC 
MODIFICATION AND INTELLECTUAL PROPERTY 
Once considered an isolated and peripheral area of law, recent works have not only placed 
intellectual property front and centre in the study of law, science, and policy but have 
considerably broadened the scope of scholarship on intellectual property to include GM and 
the biotechnology industry.87 At the same time, the GM debate that initially centred on the 
politics of regulating its risks is gradually assuming IPR as its new centrality. Even though 
Intellectual Property impacts on all the points of the food chain IP in food was for a long time 
under-theorised and had not been taken seriously until recently as the vast majority of IPR and 
IP studies continued to be about software and others. Today, the GMO discourse is slowly 
shifting discussions from risk to battling the challenges intellectual property rights poses in the 
arena. In fine, just as scholarship on GMOs has changed focus in the last two decades, so has 
the scholarly analysis of Intellectual Property.  
Presently, the impact that intellectual property laws have especially on agriculture in 
developing countries is central, complex and multi-layered. The correlation between 
intellectual property rights and the type of cultivars/seeds available, rising seed prices, can be 
predicted easily looking at the way markets work. Other effects, such as the prevalence of bio-
piracy and the loss of biodiversity, are in part facilitated by gaps in the treaty framework and the 
deficiencies in domestic legal regimes.88 The elements that impact IPRs on the Global South 
manifests in the displacement of traditional communal farming practices by corporate farming; 
disruption of established farming practices and food systems; appropriation of the genetic 
resources by corporate interests in the North; the loss of gene diversity and diminution of 
genetic variety; and discrimination against the indigenous knowledge developed within 
communities individually or collectively.89 
 
87 Biagioli, M., Jaszi, P., & Woodmansee, M. (Eds.). (2015). Making and unmaking intellectual property: creative 
production in legal and cultural perspective. University of Chicago Press. 
88 Thampapillai, D. (2015). The Food and Agricultural Organization and Food Security in the Context of 
International Intellectual Property Rights Protection. Legal Perspectives on Security Institutions, Cambridge 
University Press (2015), 269-291. 
89 ibid 
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In this chapter, we centre on the interplay of IP and GM by studying the various Intellectual 
Property Rights that move along and impact the GM food chain. IPRs such as Patent, Plant 
Varieties Protection/Breeders’ protection, Trademark, Traditional Knowledge, and 
geographical indications and the likes are sought at different stages of the food supply chain, 
and countries all over the world are under legal obligations to provide IP protection for that. 
While the type of protections differs, the prime IPRs in GM such as patent and other Sui generis 
protections like breeders' rights/plant variety, together with, some significant issues related to 
IPR protection concerns such as; Infringements and Liability, biopiracy, licensing, in Africa 
are the probing themes of this chapter.  
The principle of Territoriality on which IP operates implies IP rules are applicable only within 
a jurisdiction. 90 Therefore, the nature and scope of protection can only be guaranteed the extent 
afforded by the laws within that territory. Economic self-interest has been a central determinant 
of domestic IP laws and policies. And the use of IPRs as a means of protecting the products of 
local manufacturing when traded internationally abound. Many territories aim at protecting 
their interests and citizens, including at the expense of foreigners.91 Therefore, in our bid to 
understand and analyse GM-IP in Africa, we will begin by looking at how the IPRs came about 
and its introduction into Africa before turning to how the IPRs that affect GM is defined, 
established and operates within applicable treaties. We will then delve into the national 
legislation and regional systems like the US and EU that despite the territorial nature of IP 
hugely influences the IP regimes in Africa.  
3.1  DEVELOPMENT OF GM- IPR SYSTEM IN AFRICA 
Countries over the years have ratified IP treaties and promulgated IP laws in line with national 
interests, Exports oriented countries have tended to stronger protection that restricts access and 
causes to inflate pricing for their cultural and scientific products, while import oriented 
countries have for obvious reasons had weaker protections for imported products.92 However, 
 
90 Historically, IP territoriality has denoted three things: conferral of IP rights under the national laws of individual 
states. 2, restriction of the legal effects of those rights to the territory of their conferring state. 3 is the enforcement 
of IP rights by the courts of the conferring state applying domestic law. 
91 Drahos, P. (1999). The universality of intellectual property rights: origins and development. Intellectual 
property and human rights, 13-41. 
92 Eg. When Switzerland introduced a patent law in the late 19th century, only to protect those goods in which they 
had an established manufacturing and export industry. And left the areas where they depended on imports from 
abroad were left unprotected by patents, enabling continued free public access to chemical inventions patented 
abroad.  
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IP was introduced in Africa by colonising European countries, while Britain was exporting in 
whole its domestic IP laws to its colonies – in some cases with a level of some support by local 
ordinances,93 France and other European countries were extending their homegrown IP laws to 
their territories through assimilation and other measures.94 The genesis of African countries 
participating in international treaties was also commissioned in their absence and without their 
consent.95 Some postcolonial theorists have suggested that the current state of IP development 
goes beyond contemporary political and economic circumstances to colonial-era and the 
systematic neo-colonial arrangements like international multilateral and bilateral agreements 
that further the external economic control and industrial interests.  
Today many African countries are in the process of ratifying, implementing and adapting their 
national legislation to meet international responsibilities, often without a link between IP and 
technological developments derived internally.96 Some researchers have proposed the need to 
undertake comprehensive sectoral research to ascertain the impact each IPR or IP regime has 
on the set targets is eminent in order for the people to appreciate the need for it to be protected. 
The establishment of IP regimes should, therefore, take cognisance of both internal and external 
dynamics. A balance between access to external resources and the protection of homegrown 
ones is of the considerable essence, That is why to get a befitting IP protection regime for 
Africa’s food security and beyond, Africa must consider not only the IPRs in other jurisdictions 
but most importantly its resource endowment, historical, cultural, and socio-economic 
positioning.  
The development of IP framework should be move alongside the indigenous alternative 
rights/systems since the former’s introduction was as Yankey posits not intended to stimulate 
“indigenous activity, local research and development, innovation or to ensure the adequate 
transfer of technology, rather its objective was to safeguard the property rights of the machinery 
 
93 Kongolo, T. (2013). Historical developments of industrial property laws in Africa. The WIPO Journal, 5 (1), 
105-117. 
94 French laws until 1962, governed patent rights in the majority of francophone African countries, and the French 
National Institute for Intellectual Property (INPI) served as the central IP authority. 
95 Acquah, D. O. (2017). Intellectual Property, Developing Countries and the Law and Policy of the European 
Union: Towards Postcolonial Control of Development. Read Acquah page 183 for details on this.  
96 Brandl, K., Darendeli, I., & Mudambi, R. (2019). Foreign actors and intellectual property protection regulations 
in developing countries. Journal of International Business Studies, 50(5), 826-846. 
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technology used in the exploitation of gold and other mineral and human resources in the 
Colonies."97 
3.2  IPRS THAT IMPACTS FOOD THE GLOBAL SUPPLY CHAIN 
Even though the idea of rewarding agricultural innovations with exclusionary rights can 
originate from the 1833 Papal Edict, the underlying assumption today is that IPRs are inevitable 
within the contemporary global setting.98 IP continues to permeate into new areas as it gaining 
centrality in existing domains, and a clear example is the role Intellectual Property play in the 
biotechnology and GM industry. Many European countries began by considering IP protection 
for plant material and breeding techniques under patent law even though the consensus was 
against patenting plant materials in general. Now other sui-generis protections like Plant 
Variety Rights (PVR)/Plant Breeders’ Rights are available for GM and plant material industry, 
yet patents remain the popular IPR. While some developers opt for plant patents, many apply 
for utility patents. 
Today, developing new strains of plant material have evolved. Releasing the new variety now 
entails incorporating desired features into the variety that is being improved, examing the new 
variety over a range of habitats over time to establish its stability.99 Other modern breeding 
techniques that discover or creates a genetically stable variation for the desired plant attributes 
like high yield, pests and disease resistivity and stress-resilient are increasingly been employed 
in the process of selecting from the variations, individual plants possessing the best expression 
of the desired traits, which has now been added to the traditional breeding methods. These 
processes are very challenging as it employs several techniques and requires lots of resources 
to minimise the propensity of spontaneous genetic variation for outcomes often that will have 
the stability of intellectual products.100 
 
97 Mengistie, G., & United Nations. Economic Commission for Africa. (2010). The Patent System in Africa: Its 
Contribution and Potential in Stimulating Innovation, Technology Transfer, and Fostering Science and 
Technology. Economic Commission for Africa. 
98.' Pila and Torremans This edict extended the principles governing the reward and ownership of scientific and 
literary works in the papal states to ‘those works that relate to the progress of agriculture and its techniques 
99 Hansen, M., Busch, L., Burkhardt, J., Lacy, W. B., & Lacy, L. R. (1986). Plant breeding and 
biotechnology. BioScience, 36(1), 29-39. 
100 See A010/2013 Aurora Srl v Community plant variety Office (26 November 2014) Aurora [4] The 
inappropriateness of patent in breeding as plant varieties are as much of the products of nature as the creation of 
individuals.  
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The introduction of technology into plant and food is forcing countries to revise their IP laws, 
many nations, including some developed ones, are in the process of carving the right 
protections. Such states have to couch their protection from the policy space that is allowed 
within International treaties which and further narrowed by Trade Agreements. Others are in 
the quagmire of finding an appropriate relationship between the forms of protection as well as 
the balance between right holders and third-party interest and rights.101 Getting the right IP mix 
within the existing global structure, in particular, is an urgent matter in Africa’s bid to ensure 
food security.  
The establishment and definition of IPR in many countries often stem from international 
treaties, the operationalisation of treaty provision has not been entirely the same everywhere. 
The extent to which the increasing industrialisation of food, private sector dominance of plant 
breeding research, and gene therapies impacts decision making can account for most of the 
disparities. The discussion below with focuses on the IPRs and other sui-generis protections 
used in GM industry, with emphasis on the relationship between them, especially patent and 
PBRs/PVRs which in the face of changes in technological and economic plant breeding 
contexts continues to be a difficult one.  
Currently, most IP rights in Africa are owned by entities mainly from US and EU,102 this fact, 
coupled with the IP chapters of Trade agreements between Africa and other nations makes the 
understanding of protections in these regimes imperative in any analysis on access to GM and 
plant genetic material as a viable and effective option in remedying food insecurity. Despite 
the apparent collision of the general GM regulations, the EU and US seem to have similar IP 
for GM in both territories.103 
3.2.1  PATENTS 
Patents in general and GM patents in particular as established in treaties, the US-EU patent 
systems, Origin of African Patent and the developments GM patent. Patent-related issues 
Patents are granted on any product or process invented within the field of technology with an 
established fact that they are novel or unique, and the results from such inventions are capable 
 
101 Pila and Torremans page 235 The relationship between plant variety and patent protection 
102 Only 6 companies control 95% of gm seed worldwide 
103 Patterson, L. A., & Josling, T. (2002). Regulating biotechnology: comparing EU and US 
approaches. Environmental policy in the European Union, 183-200. 
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of being used in industrial application. Pila and Ohly define patents as the “limited-term 
monopoly rights granted in respect of new, inventive, and industrially applicable inventions.” 
Although international treaties establish patents,104 IP is territorial, and the benefits such as 20 
years monopoly that national jurisprudence allow rights holders to block others to use it for 
gainful, commercial purposes or producing same at other places without appropriate 
approval.105  
The scope of protection, the definition of critical elements, as well as the processes and 
requirements needed for a product or process to have a patent differ depending on the 
jurisdiction where patent protection is being sought. This disparity can be attributed to the most 
pervasive IP agreement of today, the TRIPs agreement,106 which has not only allowed for the 
grant of patents for everything under its system of trade law but also plagued with a number of 
interpretation variations and flexibilities, some of which are discussed below.107  
TRIPS has caused a high increase in the world’s protection of intellectual property rights and 
especially patent technology. This comprises of “any inventions, in every field of technology, 
whether products or processes, which is new, involve an inventive step and are capable of 
industrial application.”108 This definition effectively makes innovations from every industry 
capable of patents. The new biotech additions defeat the lack of technical, industrial, or 
mechanical properties of plant material inventions arguments and serve as justification for 
states that grant patents to plant materials and varieties.109 Currently, although other forms of 
IPR exists in the GM industry, Patent remains dominant despite the age-old arguments of its 
inappropriateness. Recent data show that patents continue to be the most popular intellectual 
property within the biotechnology industry contrary to the boisterous criticisms. 
 
104 Internationally, patents have moved through several treaties, since the practice of granting patents for 
inventions began in Greece - Sicily around 500 BCE, and more so after first general patent statute and patent 
specification of the 15th and 16th centuries spread across European states and the world. The recognition of patent 
as exceptions to a general prohibition against ‘odious monopolies’ in the 17th century and the patent war of the 
19th century helped reconciled the major issues such as term of protection, requirements, exclusions thus leading 
to the first international patent treaty, the Paris convention for the protection of Industrial property of 1883 
105 Article 28 TRIPS 
106 Agreement on Trade-Related Aspects of Intellectual Property Rights, April 15, 1994, Marrakesh Agreement 
Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S. 299; 33 I.L.M. 1197 (1994). 
107 Trips provide the minimum standards for IP protection and are an inescapable conditionality for joining the 
WTO. 
108 Dwivedi, D. 2015, “Trips Agreement And Protection Of New Plant Varieties: Issues And Implications For 
Agricultural Sector In India.” Vidhigya, vol. 10, no. 1, INMANTEC Institutions, p. 1. 
109 Sterckx, S. (2017). European patent law and biotechnological inventions. In Biotechnology, Patents and 
Morality (pp. 1-112). Routledge. 
 
38 
 
The agreement obligates member states to legislate laws that protect and ensure enforcement 
of rights on matters like plants that can be patented.110 It also allows member states the choice 
of protecting subject-matters like plants varieties through patents or a sui generis system, even 
though a country can adopt both.111 Because of this, the IP protection for plant and plant 
materials vary immensely in many counties. Some states have opted for patent protection for 
plants while others, tend to refuse patent protection for both plants and animals aside micro-
organisms organisms. Others also refuse essentially biological processes while allowing non-
biological and microbiological method needed in plants or animals production to be protected 
based on Article 27(3).112  
States that allow for patenting plant and plant genetic resources gives exclusive rights such as 
the right to make, offer for sale, sell, and import, in addition to, the rights to prevent others 
from exploitation if the consent of the patent holder has not been given for a period of 20 
years.113 These rights are mandatory and can only be restricted under conditions like Article 
27(2) and Article 31, which establishes a compulsory licensing regime. Whereas Article 31 
establishes a Compulsory-licensing system, Article 27(2) allows restrictions based on “ordre 
public” or morality grounds ”provided they are limited, do not unreasonably conflict with the 
normal exploitation of the patent, and do not unreasonably prejudice the legitimate interests” 
of the owner of the patent. “114  
Some states, on the other hand, exclude patents for plant varieties and provide other sui-generis 
system forms of protection for them. Several industrialised countries like the US, Japan, 
Australia, New Zealand, Sweden and the United Kingdom, have taken advantage of this to 
allow plant breeders the opportunity to protection for new varieties with patent once they meet 
some other requirements, many developing countries are refusing plant patents (Watal, 2000, 
p. 149). Countries like India, Thailand, and Malaysia have enacted separate statute applicable 
exclusively to plant varieties and plant genetic resources. These countries do not grant plant 
patents do not interpret “Using" as in a sense stated in article 28 (1) of TRIPS to include 
planting, harvesting, saving, re-planting and exchanging seeds. 
 
110 Article 27(1): Part II, section 5 of TRIPS concerning availability, scope and use of IPRs. 
111 Article 27.3.b 
112 Example of countries Biodiversity and the Law - docshare.tips. http://docshare.tips/biodiversity-and-the-law-
_576253f9b6d87f3b878b495c.html 
113 Article 28 of the TRIPS agreement list the exclusive rights available to a patent-holder 
114 in accordance with article 27 (2), 
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A variety of a plant refers to the plant grouping, within a single botanical taxon of the lowest 
known rank, it is defined by the reproducible expression of its distinguishing and other genetic 
characteristics.115 Plant varieties can either be developed natural or synthetical. GM is the way 
many plant varieties of today are developed. TRIPS, however, extends protection to genetic 
materials that have been modified at the cellular level, and not the whole genetically modified 
plant 116 This implies that inventors of plant varieties can secure intellectual property protection 
for their inventions or new products since the law provides for it. This is because living things 
can be patented and hence there is no apparent rejection for micro-organisms. TRIPS consider 
Modified genes unavailable in nature, under the ambit of patentable subject matters, as such 
the denying patents on such genes, is against the TRIPs Agreement.117 As such, it dictates that 
states should protect GMO by patent.118 Critics consider this as a breach of the ideals of many 
nations, and the reason why some developing countries are fashioning out alternate and parallel 
treaties that reflects their national interests and cultural beliefs. But protecting plant varieties 
with a system other than patents raises the challenges application of GM in plants since the 
application of GM in plants are plant related-invention that generates plant varieties.  
Distinguishing between plant varieties, and other plant-related innovations have, therefore, 
become a challenge for some nations. And this is because several states and regional laws 
usually do not allow patents for plant varieties while plant-related innovations are covered 
under patents. For instance, in Europe, article 53(b) of the European Patent Convention 
prevents the patenting of “plant varieties”. However, the European Patent Office has stated that 
broad patent claims that cover “plants” or an invention bigger beyond a single variety are likely 
to be patented although such claims might have multiple varieties.119 Plant breeders’ in Europe 
can, therefore, fashion their patents claim for new plant varieties in a way that receives de facto 
patent protection. 
In conclusion, opinions remain divided between developed and developing states since TRIPs 
does not expressly mention genes and genetic material whereas developed countries are more 
open to patents on only isolated or purified genes whereas developing countries do not allow 
 
115 Art. 2, ITPGRFA  also International Treaty on Plant Genetic Resources for Food .... http://www.fao.org/3/a-
i0510e.pdf 
116 Strauss, D. M. (2009). The application of TRIPS to GMOs: international intellectual property rights and 
biotechnology. Stan. J. Int'l L., 45, 287. 
117 Article 34 
118 Strauss, D. M. (2009) ib 
119 G 0001/98, Novartis II/Transgenic Plant, 2000; E.P.O.R. 303 para. 3.10; Janis & Kesan, 2001b, p. 35 
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for patent protection on genes and genetic material. The patentability of genes and genetic 
material, therefore, depends on the interpretation of "invention" within a jurisdiction, if a state 
considers genes and genetic material as discovery rather than invention, they will fall outside 
the scope of subjects that can be protected with patents the TRIPs Agreement. But instead, f 
genes are considered invented after having been isolated or purified,” they would fall within 
the scope of patentable subject TRIPs suggests.”120 
3.2.1.1  UNITED STATES PATENT 
The United States is one destination that has championed the patenting of biotechnology. This 
action not only been supported by various Acts such as the Plant Patent Act of 1930, and the 
Plant Variety Protection Act of 1970 and 1994, but also the courts and the effective 
enforcement strategies put in place by the U.S Patent office.121 The 1952 Patent Act established 
utility patents by giving patent holders a wide range of exclusive rights to be exercised for a 
20year period if the invention satisfies the novelty, non-obviousness, disclosure, patentable 
subject matter, and utility requirements.122 In defining ‘patentable’ subject matter, section 101 
grants utility patents for any new and employable process, machinery, and manufacture 
products as well as any advancements made to existing processes and products.123 
The landmark case Diamond v. Chakrabarty is credited for bringing living organisms or 
genetically engineered microorganism into the remit of material that can be patented under § 
101. The court believed  "Congress intended statutory subject matter to include anything under 
the sun that is made by man."124 This judgment invariably extended patents scope to almost 
everything that does not occur naturally so far as there is an element of human intervention in 
the invention and can satisfy the requirements of patentability.125 Again, the Board of Patent 
Appeals and Interferences extended patentable life forms to plants through the Ex parte 
Hibberd cause, hence, sidestepping the USPTO’s refusal of a patent application for a corn plant 
 
120 Correa, C. M. (2001). Internationalization of the patent system and new technologies. Wis. Int'l LJ, 20, 523. 
121 Section 35 U.S.C. § 161, states that: "Whoever invents or discovers and asexually reproduces any distinct and 
new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber 
propagated plant or a plant found in an uncultivated state, may obtain a patent, therefore . . . .” 
122  U.S. Patent Act of 1952, 35 U.S.C. §§ 101–103 (2000). 
123 Strauss M.  
124 Chakrabarty, 447 U.S. at 303. 
125 See, Daniel J. Kevles, Diamond v. Chakrabarty and Beyond: The Political Economy of Patenting Life, in 
PRIVATE SCIENCE: BIOTECHNOLOGY AND THE RISE OF THE MOLECULAR SCIENCES, at 65 (Arnold 
Thackray ed., 1998). 
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and opening the door for more complex living organisms for a utility patent.126 However, the 
J.E.M. Ag. Supply, Inc. v. Pioneer Hi-Bred Int’l, Inc. case ultimately confirmed that plants and 
seeds could be patented.127 The court supported the need to protect hybrid corn seeds and new 
breeds developed. Subsequent decisions have made animals and even mammals a patentable 
subject matter.  
Today, a lot of biotechnology prefer and opt for utility patents instead of plant patents; the 
USPTO commenced the issuance of Utility patents for both human-made plants and plant 
elements in the 1980s. Plant breeders prefer utility patent system because of its extensive scope. 
Even though the seed-saving and research exemptions have been narrowed by recent 
development in courts, the Plant Variety Protection Act still have both exemptions which make 
it unattractive for breeders. Utility patents aside protecting plants covers plant genes and 
include the use of the genetic material of multiple plants which may have multiple uses and 
traits. The criteria for utility patents vary from plant patents. A plant must be manufactured by 
humans aside fulfilling the basic requirements utility, novelty, and be non-obvious in the 
creation to get a utility patent. Plants that are eligible for Utility patent can be propagated from 
its seed or asexual.128 
Most developers in the GMO sector usually apply for utility patent instead of plant patents 
protection for their new and novel and hybrids plants. Players in the GMO sector, usually seek 
utility patents to protect specific elements such as genes or DNA strands, buds, proteins, pollen 
or fruit of a plant. Available data also show Utility patents for plant-based chemicals and 
processes that are used in making these products. 
Critics, however, contend that the demand for utility patent further impairs the statutory 
exemptions meant to safeguard the traditions of the small-scale farmer as well as innovative 
creations that plant breeders make. But in response, some observers have suggested that the 
increase in private sector participation in seed production,” and “the escalation in biotech utility 
patents for new varieties are rather boosting research and development activities with 
tremendous results.  
 
126 Ex parte Hibberd, 227 U.S.P.Q. 443, 443–44 (Bd. of Pat. App. & Interferences 1985). Also see arte Appeals 
Rules of Practice Before the BPAI in Ex Parte Appeals The Effective Date:  January 23, 2012 on 
https://www.uspto.gov/sites/default/files/ip/boards/bpai/procedures/og/bpai_ex_parte_rules_slides_final.pdf 
127 J.E.M. Ag. Supply, Inc. v. Pioneer Hi-Bred Int’l, Inc., 534 U.S. 124, 130 (2001), quoting Chakrabarty, 447. 
128 Holm, Sarah (2015) "When They Don't Want Your Corn: The Most Effective Tort Claims for Plaintiffs Harmed 
by Seed Companies Whose Genetically Engineered Seeds Produced More Problems Than Profits," Hamline Law 
Review: Vol. 38: Iss. 3, Article 6. Available at: http://digitalcommons.hamline.edu/hlr/vol38/iss3/6 
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With the United States being a net exporter of IP, these strong patent protections as manifested 
in acts and court's interpretations are continually being exported to other countries, and 
particularly developing countries through trade agreements like NAFTA to update IP laws in 
other regions. These extensions create difficulties for some critical exemptions, like the 
research and seed-saving exemptions, are still very relevant in developing countries, especially 
in Africa since US laws have narrowed them.129 Moreover, the Plant Variety Protection Act 
Amendments of 1994 that was enacted to make the original act fall in line with the more robust 
International Convention for the Protection of New Varieties of Plants tend to have eroded 
traditions including restricting the rights of farmers' to use, that persists in many African 
countries. Asgrow Seed v. Winterboer. 130 
 
3.2.1.2  EUROPEAN PATENTS 
Aside from the numerous international obligations, the protection of GM and plant material 
within the EU is primarily regulated by the Directive 98/44/EC (the Biotech Directive).131 This 
directive which is the core instrument for the legal protection, management and advancement 
of the biotech/GM inventions within Europe and together with the European Patent Convention 
and Plant Variety Rights systems, form the European biotechnology patent framework.  In the 
bid to ensure uniformity, the Biotech Directive has not only been transposed into national 
legislation of Europe,132 but it was also through the Decision of the Administrative Council of 
the European Patent organization (1999) incorporated into the Implementing Regulations to 
the European Patent Convention. 133  The Boards of Appeal and other quasi-judicial bodies of 
 
129 Asgrow Seed v. Winterboer, 513 U.S. 179 (1995). 
130 Pub. L. No. 103–349, 108 Stat. 3138 (codified as amended at 7 U.S.C. § 2543 (1994)) 
131 Directive 98/44/EC  
132 Patent protection in Europe is currently ensured by two systems: the European Patent System and the national 
patent systems. Even thought there may be some variations, the national patents systems are similar to the 
European patent system. This is because most of the EU member states have reconciled their national laws to the 
EU directives on IP rights protection.132 
133 Through the application for annulment of Directive 98/44/EC, brought by the Kingdom of the Netherlands, 
with the support of Italy and Norway of 19 October 1998, the compatibility of the biotech directive with 
international treaties and agreements like EPC, TRIPS, WIPO CBD, etc. was established. It appeared 
incontestable that the Directive was fully compatible with the existing deals in the field of biotechnology. In 
addition, much as the Court did not consider itself competent to assess the validity of the Directive with regard to 
the European Patent Convention, in that the European Community is not a party to it, it declared itself competent 
in relation to the legality of the Directive vis-à-vis the Convention on Biological Diversity.  
See Rule 23b explicitly lays the Directive 98/44/EC down as a supplementary means of interpreting EPC rules, 
and hence the relevant provisions of the Convention. 
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the organization have over the period profited and referred explicitly to Directive 98/44/EC as 
it functions as the primary framework for the EPC's protection of GMOs. 
Both the Biotech Directive and the European Patent Convention (EPC) make plant-related 
inventions patentable in cases where the technical feasibility of any design is not limited to one 
variety. Article 3(1) of the Biotech directive explicitly grants patent protection “for new 
inventions; which involve an inventive step and; which are susceptible of industrial application 
in products that consists of or contains biological material or a process through which organic 
materials are produced, processed or used.”134 The Biotech Directive extends patent protection 
to all material except as stated in Article 5(1) and also defines Biological material as “any 
material containing genetic information and capable of reproducing itself or being reproduced 
in a biological system.135 
The scope of patents protection conferred by EU patent generally, covers products, processes, 
and products of processes of all inventions.136 However, the patent laws in Europe do not cover 
conventional breeding patents be it the variety itself or the processes by which it is done. 
Articles 2(2), Art. 4(1)(b): Art. 4(3) Paragraph 1(b) Art. 53(b) EPC are the relevant provisions 
on the scope of process protection. In particular, where it is based on the sexual crossing of 
whole genomes and the subsequent selection of plants, […], remains excluded from 
patentability as being essentially biological within the meaning of Article 53(b) EPC. The 
directive separates plant and animals improvements that are can be patented from other 
varieties through how the product concerned is achieved. A plant variety is mostly gained 
through biological processes (sexual reproduction observable in nature), whereas non-
biological processes forming part of genetic engineering leads to transgenic plants and 
animals.137 
Patents cannot be granted to biological processes that are considered essential within the EU. 
And this is in line with Article 27 of TRIPS which only compels members to grant patent 
 
134  
135 Article 2(1)(a) og the Biotech directive - definition of Biological material”.  
136 While Art. 8(2) of the biotech directive: Art. 64(2) EPC extend exclusion from patentability of essentially 
biological methods for the production of plants to the products directly obtained by such process, the EPO 
(Enlarged Board of Appeal) argues (as decided in G2/07 and G1/08) that exclusion of essentially biological 
processes for the production of plants in Article 53(b) EPC does not have an adverse effect on the allowability of 
a product claim directed to plants or plant material such as plant parts. 
137 In the action for annulment of Directive 98/44/EC, the applicants considered the patentability of plants and 
animals provisions unclear and ambiguous, and hence a source of legal uncertainty which justified an annulment 
of the Directive. 
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protection for non-biological processes.138 However, through decisions G2/12, and G2/13 the 
EPO has affirmed that product-by-process claim for plants or plant material other than a plant 
variety define as essentially biological process for the production of plants does not preclude 
such claim per se.139 But the enlarged board has ruled that products derived from essentially 
biological processes like plants or fruits are, therefore, can be granted patent protection even 
when they are developed from a process that is not patentable . 140 
The above notwithstanding Article 9 Biotech Directive defines the scope of protection for a 
product containing or consisting of genetic information as: “However, if a process of sexual 
crossing and selection includes within it an additional step of a technical nature, which step 
by itself introduces a trait into the genome or modifies a trait in the genome of the plant 
produced so that the introduction or modification of that trait is not the result of the mixing of 
the genes of the plants chosen for sexual crossing, then that process leaves the realm of the 
plant breeding, which the legislator wanted to exclude from patentability.”141 
Some commentators have argued that article 9 extends protection to all genetically modified 
material, except as limited by the two requirements of Article 5(1) - the product first is 
integrated into another material (plant), and second, the integrated genetic information must 
perform its stated function.142  The European Court of Justice Decision court has, however, 
indicated that although genetic modification of a plant variety is not patentable, an amendment 
to the broad-spectrum, or species can be protected by a patent.143 The same court in its decision 
on 10 December 2001, has also emphasized the granting of patents for inventions relating to a 
plant variety if they meet the conditions required.144 The EBA of the EPO has ruled that in 
principle, plants can be patented if the technical features are not restricted to single plant 
 
138 Monsanto Tech. LLC v. Cefetra BV, 2010 E.C.J. EUR-Lex L.E.X.I.S. 396 (2010). 
139  
140Monsanto Slammed for Violating European Patent Law for GMO .... https://www.ecowatch.com/monsanto-
slammed-for-violating-european-patent-law-for-gmo-melon-1882159544.html. 
Enlarged Board of Appeal (EBoA)  in March 2015 on "broccoli and tomato II G2/12 and G2/13  . 
141 Minssen, T., & Nordberg, A. (2015). The Impact of “Broccoli II” and “Tomatoes II” on European Patents in 
Conventional Breeding, GMOs, and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?. Biotechnology 
Law Report, 34(3), 81-98. 
142 Conner, A. J., Glare, T. R., & Nap, J. P. (2003). The release of genetically modified crops into the environment: 
Part II. Overview of ecological risk assessment. The Plant Journal, 33(1), 19-46. 
143 Points 44 and 45 of the judgment for annulment. Also The Enlarged Board of Appeal of the European 
Patent Organisation’s decision of 20 December 1999 is based mutatis mutandis on the same considerations 
as contained in Directive 98/44/EC, viz. 
144 The Court rejected the arguments in Point 43 of the judgment and referred to the substance of Article 4 
of the Directive,which lays down that a patent cannot be granted for a plant variety, but may be for an 
invention if its technical feasibility is not confined to a particular plant variety 
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variation.145 This ruling implies that within the EU,  plant inventions fall under patentable 
subject matters if that invention can be carried out on several plants.146 
The CJEU ruled in the Monsanto case that genetic inventions contained in patented products  
must perform its duty in the material and not be merely present, in order to clarify the scope of 
the legal protection discussed on biotechnological inventions provided for in Article 9. That is, 
protection is limited to stated claims and the actual application of the stated claims. 
Consequently, European biotechnology patent protection is only valid provided that the 
function of the patented gene is congruent to its indication.147 Accordingly, a claim to a DNA 
or genetic modification sequence is enforceable within the EU when the sequence is proficient 
in executing functions for which it was created.148 Protection granted under Article 1(2) of 
Directive 98/44/EC is thereby not absolute. The escape clause that was possibly created by the 
case’s ruling could have a high impact on companies like Monsanto, but some scholars have 
also suggested it will weaken the attempts for global intellectual harmonization.  
Published patent applications, by the European Patent Office from 1995 to date indicate much 
higher applications in Genetically Modified plants than conventional forms, most of these 
patents have been secured under a utility patent. Utility patent was only open for cultivars in 
Europe from 2015. EU utility patent have breeders; exemption149 France, Germany, 
Switzerland, and the Netherlands have breeders’ exception in their utility patent even though 
some form of licensing may be needed.  
In January 2018, the European Patent Office rescinded the CRISPR-Cas9 patent initiated by 
the US-based Broad Institute. The decision was based on whether the EPO had the power to 
decide on Broad’s entitlement for priority since the patent originates from the US. By 
implication, the judgment on this case was likely to affect every industry that employs genetic 
technology scientifically. The impact of these rulings and the general position of the EU patent 
 
145 Monsanto Slammed for Violating European Patent Law for GMO .... https://www.ecowatch.com/monsanto-
slammed-for-violating-european-patent-law-for-gmo-melon-1882159544.html. The legal definition for invention 
in Europe is based on the Bundesgerichtshof (German supreme court) in Red Dove X ZB 15/67, [1970] IIC 136, 
where the court decided that an invention comprising of teaching methodically to utilize controllable natural forces 
to achieve a causal, perceivable result that can be repeated an arbitrary number of times obtaining the same result 
each time and the breeding method in issue could not be repeated to produce a dove. 
146 Monsanto Slammed for Violating European Patent Law for GMO .... https://www.ecowatch.com/monsanto-
slammed-for-violating-european-patent-law-for-gmo-melon-1882159544.html 
147 C-428/08 Monsanto Technology LLC, the judgment of 6 July 2010 
148 Biological inventions (Supplementary reading).  
https://e-courses.epo.org/wbts_int/litigation/BiologicalInventions.pdf 
149 Initiated by the Plantum (umbrella organization for commercial seed companies in Netherlands) 
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can in no way be underestimated since EU rule-making affects other countries in immense 
ways.150 The EU, in particular, has an Economic Partnership Agreement with Africa, in which 
stricter and enhanced IP updates that may not necessarily be conducive for promoting access 
to food, medicines, and development, in general, are drafted for African nations to consider.  
3.2.1.3  AFRICAN PATENT. 
Many African countries signatories to international treaties and bilateral agreements which 
have IP clauses that press for a broader patent scope, these treaties and agreements have 
generally shaped the IP regime in many African countries. Some researchers consider TRIPS 
and bilateral agreements like the US FTAs and EU’s EPAs as the contributors of both the type 
and scope of patents protection in Africa even though the scope of patent protection seems to 
differ differs from nation to nation. Several studies on the region indicate that the majority of 
the countries in Africa granting patent protection for inventions are as a result of treaty 
obligation or trade agreements.   
In accordance with the latitude that TRIPs give in Article 27(3)(b) of the TRIPS Agreement, 
several developing countries have excluded patents for plants varieties with the intention of 
providing sui-generis protection. But, TRIPS is unambiguous in demanding patent protections 
for GMOs. Many African states have been slow in acknowledging the presence of GM in their 
territories, let alone enact laws for them. Only a few countries that are into GM cultivation are 
also yet to finalize the regulations on them. Mauritius have a GMO act, but it makes no mention 
of intellectual property rights. 
South Africa’s patent laws exclude plant and animal varieties; however, the exclusion does not 
cover microbiological processes like plants modified through genetic engineering.151 This 
exclusion, however, creates a situation  where plants and plant products could be the subject of 
both patents and breeders’ rights laws. This dual protection possibility can also be seen in the 
Ethiopian patents and breeders laws. 
Some scholars have opined that patents are western in that they protect formal practices and do 
not  recognize other farming practices and privileges in Africa and other developing countries 
yet even countries that are not under obligations are being influenced to follow suit. Ethiopia 
 
150 Acquah D. O. (2017) id 
151 Sileshi, B. (2012). The Possible Overlap between Plant Variety Protection and Patent: Approaches in Africa 
with Particular Reference to South Africa and Ethiopia. Haramaya Law Review, 1(1), 125-136. 
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is not a member of TRIPS and is therefore not obliged to follow the provisions TRIPs demands, 
even though the country acceded to the WTO in 2003. Nonetheless, the patent and plant variety 
laws that Ethiopia legislated in 1995 and 2005, respectively grant patents that are similar to 
TRIPS rather than the African Union Model Law or the CBD, to which they are signatories 
to.152 Table 3 shows the type of protection each nation offers. 
 
3.2.2. SUI-GENERIS 
“Plant breeding is a highly resource-consuming activity. It takes several years to develop a 
variety and requires a lot of financial resources, equipment, and skilled workforce” (Jördens 
and Button, 2011). 
Although patent continues to dominate, the rationale for granting IP as a mechanism for 
encouraging developments of new plant material has led to many questioning the 
inappropriateness of patent protections for food on public interest grounds while advocating 
for other sui-generis forms of protection.153 The term sui-generis refers to any “unique” system 
created to give protection, it gives room for flexibility in the scheme of plant variety protection. 
Sui-generis plant protection also gives a broader spectrum for policy alternatives since it can 
even include systems  that acknowledge innovators, with or without compensation or individual 
monopoly rights.154 A sui-generis IP system is, therefore, a set of rules designed to the 
particular features of the subject matter for which protection is being given.155 It is a form of 
protection TRIPS suggests for protecting plant genetic material aside patents. Sui-generis are 
different from patents in may regards.156 
 
152 A Proclamation Concerning Inventions, Minor Inventions and Industrial Designs Proc. No. 123/1995, 
NEGARIT GAZETA OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA [hereinafter Patent Proc.]; 
Plant Breeders‘ Right Proc. No. 481/2005, FEDERAL NEGARIT GAZETA [hereinafter Plant Breeders’ Proc.]. 
also Ethiopia ratified the CBD on July 4, 1994, and UPOV on October 2, 2005. The country has also ratified the 
International Treaty on Plant Genetic Resources for Food and Agriculture (2001). 
153 Batur, F., & Dedeurwaerdere, T. (2014). The use of agrobiodiversity for plant improvement and the intellectual 
property paradigm: institutional fit and legal tools for mass selection, conventional and molecular plant 
breeding. Life sciences, society and policy, 10(1), 14. 
154 Pila, J., & Torremans, P. (2019). European intellectual property law. Oxford University Press, USA. 
155 Correa, C. M., Shashikant, S., & Meienberg, F. (2015). Plant variety protection in developing countries: A tool 
for designing a sui generis plant variety protection system: An alternative to UPOV 1991. By: Association for 
Plant Breeding for the benefit of society (APBREBES) and its member organizations: Berne declaration, the 
development fund, SEARICE and third world network. 
156 Protection offered is much less than a patent, even though it is less expensive, and the proof and documentation 
requirements are less intensive. The types of plants that can be protected are not limited as they are in plant 
patenting.  And  farmers can save and reuse seeds from protected plants or sell the seeds for use on other farms in 
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There are many forms of sui-generis protection as the nature of a sui-generis regime is based 
on the objectives and prevailing interests. The focal subject often alternates around themes like 
commercial or farmers’ variety; the scope of rights conferrable; the conditions that applicants 
or rights holders must satisfy; and the recognition of farmers’ rights as defined by ITGRFA. 
These are what Correa has identified as the distinguishing elements of the forms of sui-generis 
protection.157 In this section, we look at the types of sui-generis protections available and how 
each is established in line with Correa’s taxonomy. We discuss Plant Breeders’ Rights, and 
Plant Variety Protections as against the Indian, and the African model of protections along the 
lines of coverage (new, extant, commercial, traditional, wild, farmers variety); protection 
requirements (novelty, distinctness, Uniformity and stability NDUS); rights conferred; rights 
holders. These elements form the basis of divergence between the UPOV model and the other 
sui-generis protection models.  
3.2.2.1 PLANT BREEDERS’ RIGHTS 
Plant breeding programs based on conventional and biotechnological methods require massive 
investments, both in scientific intelligence and skills, and in economic terms, yet, once a variety 
is evolved, it is easier to reproduce, multiply or sell the seeds of the improved varieties without 
the knowledge or consent of the breeder. The concept of plant breeders’ rights was thus 
introduced to strengthen compensation efforts for the commitments and investments. PBRs 
originated in developed countries where private companies have been essential players in plant 
breeding research, seed production and marketing.158 Today PBRs are prominent within 
international agreement and variants of PBR can be found in different jurisdictions.  
The Union for the Protection of New Varieties of Plants (UPOV) Plants Breeders Rights (PBR) 
system has been the default model many nations adopt in their implementation of a sui generis 
system of protection for plant varieties as required by TRIPS even though article 27 does not 
refer to any preexisting legal regime (Correa 2015). UPOV has two models of the sui-generis 
system , (the 1991 and 1978 models), and states that signed the GATT accord are obliged to 
 
contrast to Article 14 which gives patentee rights to prevent others from producing or reproducing, conditioning 
for the purpose of propagation, offering for sale, selling or otherwise marketing, exporting, importing, and 
stocking for any of the purposes for the relevant plant materials. 
157 Correa M, id 
158 Tansey, G. (2011). Whose power to control? Some reflections on seed systems and food security in a changing 
world. IDS Bulletin, 42(4), 111-120. 
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choose either the 1978 provisions or the 1991 Convention even though both systems differ on 
some core issues like farmers rights.159  
UPOV’s Plant breeders’ rights are significantly different from patents. The requirement criteria 
for PBR protection are not rigorous, but the bounds of security or safety granted is quite narrow 
by way of the exclusive rights and the exceptions and limitations, unlike patents where the 
requirements that need to be satisfied before a product or process is eligible are high and 
challenging, albeit for the broader rights. A state may adopt either or both forms of protection 
depending developmental stage of its plant breeders’ industry. 
Under the UPOV Convention, the Novelty Distinctness, Uniformity, and Stability criteria are 
employed to confer exclusive rights to authorise the production or reproduction, cultivation, 
selling/marketing, exporting and importing,  as well as the stocking for any purposes of 
propagating material of the protected variety,160 for new varieties over a period 15 to 20 years, 
based on the type of species. PBR rights do not include traditional varieties, and the 91 model 
makes farmers’ rights optional in article 15(2).  
Currently, plant protection other than patents in several countries is based on the UPOV 91 
model. Europe, for example, has a Plant Variety Rights Protection that stems from UPOV. 
Some states such as Thailand and India have, however, enacted versions of sui-generis systems 
for protecting all plant species and kinds, in compliance with the TRIPs but not necessarily 
UPOV standards (discussed in 3.1.2.2).161 This is because many researchers argue that the 
UPOV, particularly the ‘91 Convention, is least suited for challenges in developing countries 
where the majority of the farmer are in the informal seed sector.162  
3.2.2.2  PLANT VARIETY RIGHTS 
Plant Variety Rights (PVR) are sui generis rights conferred on application to breeders of a 
particular strain of plant material. It is Europe's response to plant patent, and the natural system 
that evolved in Europe after Netherland and Germany gave breeders exclusionary rights in 
respect to new strains of plant material depending on the principle of minimum standards and 
 
159 Group, The Crucible. People, Plants, and Patents: The Impact of Intellectual Property on Trade, Plant 
Biodiversity, and Rural Society, International Development Research Centre, 1994. ProQuest eBook Central, 
http://ebookcentral.Created from kutu on 2019-05-08 04:13:32. 
160 Article 14 lists the rights accorded breeders’ under the UPOVconvention 
161 SSRN-id2619763.pdf India, 2001; Thailand, 1999. 
162 National and Regional Plant Variety Protection Legislation .... http://www.apbrebes.org/content/national-and-
regional-plant-variety-protection-legislation-developing-countries 
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national treatment.163 It is also the reason for the call for EEC members to exclude plant 
varieties from European patentability as in Article 2(b) SPC and Art 53(b) EPC. The PVR 
system in Europe without prejudice to the national property protection for variety makes room 
for a Community Plant Variety Rights (CPVR) system, and breeders must choose between the 
community and national PVR for any given variety. 
PVR allows Union members to recognise new plant variety and requires them to grant breeders' 
protection on the plant genera and species they develop.164 The subject matter protectable under 
CPVR is plant variety; however, a plant is legally defined in EU to include all botanical genera 
and species, varieties as well as hybrids between them.165 A variety, on the other hand, means 
“plant grouping within a single botanical taxon of the lowest known rank”.166 Article 19 gives 
trees and vines 25 years of protection while other species receive 20 years of protection.167 A 
subject matter is required to be capable of definition, distinction, and consideration as a unit to 
constitute a variety. This adds up to the overall demands of novelty and DUS (distinctness, 
uniformity, and stability) condition. Even though novelty here is derived from Article 10 of 
UPOV, it is different from novelty under European Patent law. The former uses commercialize 
instead of made available to the public. 
In the Sakata case, an invention was explained to include not only new developments but the 
planting, selection, and growing of materials and its development that existed before it became 
a finished variety as well. The Keith Kirsten case also had the Board of Appeal expanding a 
variety to include when a person comes across a variety deliberately or by chance, so far as 
they are conscious that it was a new variety they did not know, and believe the variety to be 
unknown to other persons as well with or without commercial potential.  The same variety can 
be independently discovered by two or more at the same time. 
The CPVR gives exclusive rights similar to utility patents. These rights include the rights to 
“produce and reproduce, condition for propagation, sell, market, import and export to the 
 
163 Trommetter, M. (2010). Flexibility in the implementation of intellectual property rights in agricultural 
biotechnology. European journal of law and economics, 30(3), 223-245. 
164 Article 3 of the PVP 
165 1991 UPOV Convention Act 
166 Plant grouping consisting of entire plants or parts of plants as far as such are capable of producing entire plants 
(variety constituents); the expression of characteristics referred to in paragraph 2 of Article 5. Central to the 
definition is the reference to taxonomic rank, which restricts the subject matter for which CPRVs may be granted 
to plants positioned at the bottom of the taxonomic hierarchy, immediately beneath the rank of genus 
167 Article 1 of UPOV convention 
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Community” as well as the piling of a variety harvested. Article 13(2) and 13(5) makes the use 
of protected varieties in developing non-distinct and hybrid varieties an infringement.168 
However,  article 13(8) to 15 of the basic rule tries to provide a balance between the rights of 
breeders on the one hand, and the interests of farmers and the broader society on the other. 
These exceptions and limitations articles make public morality, public policy or security, the 
health and life of humans, animals or plants protections, the protection of industrial or 
commercial property, the protection of the environment, or the safeguarding of competition of 
trade or agricultural production legitimate grounds for restricting the rights given to breeders. 
Article 15(1) also allow farmers to use in their fields propagating materials they get cultivation 
so far as they are not from a hybrid or synthetic variety. 
Farmers privilege under PVR applies only to plants under art. 14(2) (rice, peas, beans, and rye), 
and even subject to obligations such as the equitable payment remuneration (except small 
farmers) of a reasonable amount below what the license holder would usually charge within 
the area.169 According to the court of justice in case c-242/14 Saatgut-Treuhandverwaltungs 
GmbH v Gerhard und Jurgen Vogel GbR EU:c:2015:422, while the farmer need not pay the 
equitable remuneration to the holder in advance of planting the relevant farm-saved seed, nor 
does the period which she has for paying it to continue indefinitely. Instead, to be able to benefit 
from Article 14 privilege, the farmer must pay the remuneration before the marketing year for 
that planting season. Secondly, affected farmers and suppliers of processing services are 
required to provide information concerning the issues of art 14(3) when the  CPVR holder asks.  
Currently, most patent-related issues seem to be well resolved in the European context, but a 
number of concerns regarding plant protection remain hanging, the interface between patent 
and PVR in defining the scope of product protection is one of such, that is the patent regime to 
a large extent may be unambiguous since in practice plant varieties are within the scope of 
patents.170 But since plant invention can either be protected by patent or PVR, many experts 
have argued for, at least clarifications, that better distinguishes between the areas of plants 
inventions that can be patented and plant variety rights, especially inventions relating to plants 
developed through an essentially biological process.  
 
168 Bart Kiewiet, Plant variety protection in the European Community, 0172-2190/$ - see front matter _ 2005 
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170 Addressed in G1/98 see in particular Article 64 EPC; Article 4(2) and Articles 8 and 9 of the biotech directives 
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In the US, the Plant Variety Protection (PVP) is a certification process which gives breeders 
control on specific plant varieties invented or discovered. The PVP aims at protecting natural 
material. As such breeders' rights under PVP excludes “technical processes” employed in the 
production of the varieties, and therefore, do not extend to breeding methods or systems. While  
first-generation hybrid varieties are excluded under the act, plants that are propagated by seed 
and tubers, as well as F1 bacteria, fungi and  hybrids all fall within the scope of the PVP 
3.2.2.3  THE INDIAN MODEL 
India in 2001 enacted the Protection of Plant Varieties and Farmers' Rights Act, 2001 (PPVFR, 
this act established a system for protecting plant varieties, farmers and plant breeders. Its 
objective was to promote the development and cultivation of new plant varieties. Before the 
act, India’s patent and design laws (1970) considered all plant genetic resources as public 
property and did not assign any IP protection for pharmaceuticals, food, and agrochemicals and 
methods of agriculture and horticulture innovations. The PPVFR act was therefore in response 
to the Trips agreements requirements, in particular, Article 27.3(b). The PPVFR establishes a 
dual right system,  first for the variety, and then the breeder. The rights granted under the 
PPVFR are heritable and can also be transferred to others only when the variety is registered. 
The PPVFR combines the rights of both breeders and  farmers, it protects breeders and at the 
same time, grants extensive rights to farmers. By this breeders/researchers are allowed to use 
a protected variety for further breeding/research, while farmers’ rights to sow, re-sow, sell or 
save seeds of protected variety from their harvest is also guaranteed. The act recognises farmers 
as cultivators, conservers of agricultural biodiversity, and breeders of plant varieties. It 
considers farmers as the custodian of the local variety or community as conservers and selectors 
of germplasms.  
The general protection requirements of novelty, distinctness, uniformity and stability,171 is not 
applied in all circumstances. The novelty principle, for example, does not apply to extant 
varieties according to Art 15(2) even though the other requirements must be satisfied; This 
significantly broadens the scope for to include varieties that have previously been 
commercialised or offered for sale.  
The Indian act also differs with the UPOV on the coverage. It grants protection to categories 
of varieties, and the PPVFR applies to not only new plant varieties but also varieties developed 
 
171 Novelty, distinctiveness, and stability are the criteria for the PPVFR  
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by farmers’ under the Extant (domestic and existing) Varieties umbrella. This variety includes 
plants or materials that have been propagated and developed commonly by farmers as well as 
the wild-relative or landrace varieties that farmers and the community, in general, have shared 
knowledge on.172 Extant varieties/farmers varieties are usually accorded exclusive rights 
similar to that of new varieties, and given broader exceptions like the ways seeds could be 
reused, saved, use, sow, re-sow, exchange, share and even sell products, such as seeds of 
protected varieties.173 In addition Essentially Derived Varieties (EDV), be it new or extant can 
be registered. 
Breeders’ are given 15 years protection term for field crops and 18 years in the case of trees 
and vines, subject to renewal fees and fulfilment of other condition. Notified varieties also 
receive fifteen years from the date it was applied for under section 5 of Seeds Act, 1966. A 
person selling, exporting, importing or producing protected varieties requires the permission 
of the breeder, failure to do so infringes on the registered license and therefore liable to a fine 
or imprisonment six months and three years. This also applies in cases where a denomination 
is deceptively similar or capable of being confused with the denomination of a registered 
variety. 
Farmers on the hand are equally entitled to save, use, sow, re-sow, exchange, or sell produce 
they obtained from their farms even if they are seeds of a variety that has been registered 
unrestrictedly. Farmers' can also register their varieties, to secure the exclusive rights to 
produce, sell, market, distribute, import and export the variety. In addition, they are absolved 
from all fees relating to any proceedings. Again, in cases where a registered variety is unable 
to perform the function, it is expected to do, farmers have to the right to demand compensation. 
Efforts by communities that help to conserve or evolves any variety also need to be 
compensated when it is being used to develop other varieties.174 All these rights, together with 
provisions relating to benefit sharing, can be enforced under Civil and criminal law. 
Exception u/30 allows scientists and researchers to have access to the registered variety for 
experiment or research purposes. Registered varieties can also be used as a primary source of 
a variety for evolving other varieties without the prior approval of the breeder. However, one 
needs to seek the permission of the of breeder when developing a new variety for commercial 
 
172 Article 2(1) 
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production involves using a parental line of a protected variety repeatedly. The PPVFR also 
permits compulsory license in the case where the price of a variety registered is restricting the 
public from having access . 
In conclusion, the extensive liberties with respects to both farmers' and breeders' rights makes 
it incompatible with neither UPOV 78 nor UPOV 91 since farmers are permitted to sell seed 
of protected varieties. But India is a WTO member, and its PVPFR is, therefore, an alternative 
to UPOV that other WTO member can emulate for plant variety protection. The Indian Act is 
the first in the world to give formal rights to farmers without jeopardising the rights of 
researchers and breeders. 
3.2.2.4 THE AFRICAN MODEL 
In 2000, the OAU developed a model that sought to give directions to sovereign states on how 
to approach plant varieties protections in a way that traditional and indigenous technologies 
complemented by appropriate modern technologies can be promoted and supported. This 
model specifically aimed at preventing encroachment into the realm of community livelihood 
systems in Africa and following the obligations of TRIPS 27(3) for a sui-generis option on one 
hand and upholding Africa’s commitments under the CBD on the other. 
Under the African Model, PBRs are formulated in such a way that traditional community 
innovations and propagating methods are not subverted by modern practices of commercial 
nature.  It protects the rights of breeders, farmers, and communities. The model prioritises 
access to biological resources by acknowledging that communities have rights over the natural 
resources, knowledge and technology that they have been developed over generations. And 
that these endogenous resources are the collective right of the people which takes preeminence 
over other private rights. It, thus, shares similar objectives with the Indian model and 
contradicts the aim of international and regional trade and IP organisations in Africa for the 
establishment of a harmonised PVP law based on UPOV '91.175  
Premised on the fundamental understanding the survival of all humanity depends on life which 
is fundamental human right as in Article 9, the model does not allow patents on life nor the 
exclusive appropriation of parts or derivative of it.176 Article 28 defines breeders’ rights and 
 
175 Oguamanam, C. (2018). Plant Breeders’ Rights, Farmers’ Rights and Food Security: Africa’s Failure of 
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accord it with protection duration term similar to the UPOV standards; however, it departs from 
the NDUS criteria for protection and sets its protection requirement under Articles 25(2) and 
29.177 With emphases on Specific attributes identified by a community as the protection 
requirement, this model disregards the NDUS criteria. Correa has noted that the unclear nature 
of the attributes that should be considered and how they are to be determined could cause many 
ambiguities and competing on claims to ownership. 
Breeders' Rights under the African model, however, are restricted by conditions under Farmers' 
Rights in respect of a plant variety, they also require higher approval criterion that involves 
statistically valid, multi-locational trials for plant varieties originating from outside a 
country.178 Farmers right as in Article 24 is discussed in section 3.3.2.1 of this paper. The model 
also recognises, protects and supports the natural rights that local communities have like 
farming practices and IP rights; it provides a system that will facilitate access to biological 
resources. Moreover, technologies that are derived from the knowledge and traditions of 
communities must have the consent of that community and the State.179  
So far, it is yet to be known the number of countries that have taken inspiration from the African 
model. Correa has noted that this model has not been incorporated into national legislation of 
member countries. Zambia’s attempt to legislate a bill that combined breeders rights and 
farmers rights in line with the African Model and the ITPGR for example first saw the isolation 
of both rights and then the passage of only the breeders' rights akin to the UPOV due to 
international pressures for reasons that the breeders' rights were more urgent. In effect, the 
Zambian model that began as sui generis bill has no specific provisions on farmers varieties 
 
1) Patents over life forms and biological processes are not recognised and cannot be applied for. 
2) The collector shall, therefore, not apply for patents over life forms and biological processes under this 
legislation or under any other legislation relevant to the regulation of access and use of a biological resource, 
community innovation, practice, knowledge and technology, and the protection of rights therein. 
177 Article 25(2) A variety with specific attributes identified by a community shall be granted intellectual 
protection through a variety certificate which does not have to meet the criteria of distinction, uniformity and 
stability. This variety certificate entitles the community to have the exclusive rights to multiply, cultivate, use or 
sell the variety, or to license its use without prejudice to the Farmers' Rights set out in this law. 
178 Artile 43 of the African Model 
179 Article 23 Recognition of Community Intellectual Rights The Community Intellectual Rights of the local 
communities, including traditional professional groups, particularly traditional 
practioners, shall at all times remain inalienable, and shall be further protected under the mechanism established 
by this legislation. And argues in clause 3 that Non-registration of any community innovations, practices, 
knowledge or technologies, is not to mean that these are not protected by Community Intellectual Rights. 
4) The publication of a written or oral description of a biological resource and its associated knowledge and 
information, or the presence of these resources in a genebank or any other collection, or its local use, shall not 
preclude the local community from exercising its community intellectual rights in relation to those resources. 
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due to constant pressure from private seed developers, international UPOV and external seed 
companies.180 This example exposes the enormous role of foreign influence and domestic 
pressure from seed companies in the enactment of the law process.  The African model can still 
be an inspiration going forward. 
In conclusion, tour African countries, aside from the 17 nations that the African Intellectual 
Property Organization (OAPI) plant breeders’ rights system covers have acceded to the UPOV 
convention.181 This means that the majority of the countries in Africa that seeks to protect plant 
variety by means other than patent and are not members of UPOV have the privilege to develop 
their form of protection along with the African model. The reality, however, is that countries 
like Ghana, and Malawi who are not members of UPOV, in spite of widespread criticism and 
protests, have modelled their Plant variety protections along UPOV lines and without fully 
exploring Trips flexibilities. 
There is yet to be any nation in Africa that has modelled its sui-generis protections along with 
the Indian model. It is also important to note that even though many countries in Africa have 
tailored their sui-generis protection along the UPOV lines, there are still marked differences 
between them. Correa has, for instance, indicated that Kenya allows plant breeders’ rights to 
all plant genera and species except algae and bacteria, the laws in Egypt makes it mandatory 
for the origin of the breeding material and the source of the knowledge used in developing the 
variety must be revealed. No African state has developed a model unique enough for 
acknowledgement and replication.  
The sui-generis law in itself may not be the solution especially as external pressure do force 
farmers to abandon the set standards for higher ones in order to gain access to international 
markets etc. however, Correa has listed of expected elements of a good sui-generis as equity, 
conservation, preventing misappropriation, dissemination of knowledge, farmers rights, 
incentive. These elements were deduced from comparing the available sui-generis protection 
and the rationale for their demand. The potential conflict in policies and regulations like the 
acknowledgement of Farmers' Rights as expressed in the International Treaty on Plant Genetic 
Resources for Food and Agriculture (ITPGRFA) has also led to calls for the continent to 
develop its sui generis protection that will focus on local variety and practices.  
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3.2.2.4 THE AFRICAN MODEL 
In 2000, the OAU developed a model that sought to give directions to sovereign states on how 
to approach plant varieties protections in a way that traditional and indigenous technologies 
complemented by appropriate modern technologies can be promoted and supported. This 
model specifically aimed at preventing encroachment into the realm of community livelihood 
systems in Africa and following the obligations of TRIPS 27(3) for a sui-generis option on one 
hand and upholding Africa’s commitments under the CBD on the other. 
Under the African Model, PBRs are formulated in such a way that Africa’s long tradition of 
community innovations and breeding are not undermined by new norms of commercial nature.  
It protects the rights of breeders, farmers and the Local Communities. The model prioritises 
access to biological resources by acknowledging that the rights of local communities over their 
natural resources, knowledge and technology that have evolved over generations are a 
collective nature and is, therefore, are a priori rights which takes precedence over rights-based 
on private interests. It, thus, shares similar objectives with the Indian model and contradicts the 
aim of international and regional trade and IP organisations in Africa for the establishment of 
a harmonised PVP law based on UPOV '91.182  
Premised on the fundamental understanding that all forms of life are the basis for human 
survival and a fundamental human right as in Article 9, the model prohibits the patenting of 
life or exclusively appropriating any life form or part or derivative thereof.183 Article 28 defines 
breeders’ rights and accord it with protection duration term similar to the UPOV standards; 
however, it departs from the NDUS criteria for protection and sets its protection requirement 
under Articles 25(2) and 29.184 With emphases on Specific attributes identified by a community 
as the protection requirement, this model disregards the NDUS criteria. Correa has noted that 
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the unclear nature of the attributes that should be considered and how they are to be determined 
might lead to significant uncertainty and competing claims about ownership. 
Breeders' Rights under the African model, however, are subject to the conditions provided in 
the Farmers' Rights in respect of a plant variety, they also require higher approval criterion that 
involves statistically valid, multi-locational trials for plant varieties originating from outside a 
country.185 Farmers right as in Article 24 is discussed in section 3.3.2.1 of this paper. The model 
also recognises, protects and supports the inalienable rights of local communities including 
farming communities and their IP rights by providing an appropriate system of access to 
biological resources, community knowledge-based technologies are subject to the prior 
informed consent of the State and the concerned local communities.186  
So far, it is yet to be known the number of countries that have taken inspiration from the African 
model. Correa has noted that this model could not make its way into the national legislation of 
member countries. Zambia’s attempt to legislate a bill that combined breeders rights and 
farmers rights in line with the African Model and the ITPGR for example first saw the isolation 
of both rights and then the passage of only the breeders' rights akin to the UPOV due to 
international pressures for reasons that the breeders' rights were more urgent. In effect, the 
Zambian model that began as sui generis bill has no specific provisions on farmers varieties 
due to constant pressure from private seed developers, international UPOV and external seed 
companies.187 This example exposes the enormous role of foreign influence and local pressure 
from seed companies in the enactment of the law process.  The African model can still be an 
inspiration going forward. 
In conclusion, tour African countries, aside from the 17 nations that the African Intellectual 
Property Organization (OAPI) plant breeders’ rights system covers have acceded to the UPOV 
convention.188 This means that the majority of the countries in Africa that seeks to protect plant 
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variety by means other than patent and are not members of UPOV have the privilege to develop 
their form of protection along with the African model. The reality, however, is that countries 
like Ghana, and Malawi who are not members of UPOV, in spite of widespread criticism and 
protests, have modelled their Plant variety protections along UPOV lines and without fully 
exploring Trips flexibilities. 
There is yet to be any nation in Africa that has modelled its sui-generis protections along with 
the Indian model. It is also important to note that even though many countries in Africa have 
tailored their sui-generis protection along the UPOV lines, there are still marked differences 
between them. Correa has, for instance, indicated that Kenya grants plant breeders’ rights to 
all plant genera and species except algae and bacteria. Egypt also requires disclosure of the 
source of breeding material and knowledge. No African state has developed a model unique 
enough for acknowledgement and replication.  
The sui-generis law in itself may not be the solution esp as external pressure will force farmers 
to abandon the set standards for higher ones to gain access to international markets etc. 
however, Correa has listed of expected elements of a good sui-generis as equity, conservation, 
preventing misappropriation, dissemination of knowledge, farmers rights, incentive. These 
elements were deduced from comparing the available sui-generis protection and the rationale 
for their demand. The potential conflict/gap in policy and legislation example, the recognition 
of Farmers' Rights as expressed in the International Treaty on Plant Genetic Resources for Food 
and Agriculture (ITPGRFA) has led to calls for the continent to develop its sui generis 
protection that will focus on local variety and practices.  
 
3.3  IPR RELATED ISSUES 
3.3.1  FARMERS RIGHTS 
The concept of farmers’ rights was advanced to counter-balance the property-based response 
to the imbalance between Northern intellectual property rights and rights of Southern farmers; 
it aims to vest quasi-intellectual property rights in the latter.189 Over the years, IPRs in 
agriculture have been conferring rights on Northern actors while the contribution of Southern 
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farmers has gone uncompensated.190 Within the same period, international trade has affected 
domestic farming by disrupting traditional farming practices and jeopardising food security. 
Accordingly, farmer’s rights are often advanced to recognise the contributions of farmers to 
plant genetic resources development and conservation as well as food security. 191 
The first international instrument to effectively allude to farmer’s rights is the non-binding 
agreement on Plant Genetic Resources, developed by the Food and Agricultural Organisation 
in 1989. It's Resolution 5/89 brought farmer’s rights within the framework of International 
Undertakings. This  came about as the Global South sought for an open-access approach to 
plant genetic resources that will counteract the Breeders’ Rights created by UPOV. However, 
the Resolution and the original text of the agreement embodied two separate approaches to 
farmer’s rights. The first being the common heritage of humankind stated in Article 1 of the 
Undertaking, and the second, the privilege or property-based approach that linked farmer’s 
rights to new IP concepts like traditional knowledge. While the former benefits farmers by 
preserving access and diversity, the latter method provides a basis for farmers to either receive 
compensation for their efforts or to be afforded concessions relative to traditional farming 
practices.192 
The clear difference between western IP and FR is the former lacks the level of enforceability 
within intellectual property rights. This inadequacy provides food security institutions such as the 
FAO with a limited range of policy options that they can feasibly pursue. Besides, the non-binding 
Resolution 5/89 did not specifically define Farmers’ right even though FR generally include 
the right to save, replant and share seeds.  These shortfalls made the undertaking an inadequate 
mechanism for achieving the farmer’s rights. Nevertheless, the International Undertaking did 
influence the drafting of the CBD, and the access and benefit-sharing scheme in the ITPGRFA. 
The absence of any specific definition of farmer’s rights, in turn, impacts upon the content of 
the rights. 
Article 9 of ITPGRFA provides the legal recognition of the concept of farmer’s rights, more 
effective than the International Undertaking or FAO Resolution 5/89. These rights are 
fundamental to traditional smallholder and subsistence farming. However, while there is some 
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clarity in ITPGRFA as to the form and manner of farmer’s rights, the problem of how those 
rights are to be given effect within international economic laws and treaties like TRIPS lingers. 
The informal nature of the practices means farmers find it hard to meet specific standards like 
stability and uniformity set by regimes like UPOV because varieties developed farmers are less 
stable over time.193 Some scholars have argued for alternative standards since the strict 
application of the NDUS requirements often leads to farmers’ varieties unqualified for 
protection.194 
Farmers rights under India gives the farmer the normal rights to use, sow re-sow, share, 
exchange, or sell produce from their farms.195 In addition, farmers are allowed to save but are 
not allowed to sell branded seed of varieties that are protected under the law. It also sets farmers 
not only as conservation agents but allow new varieties they develop to be registered and 
protected in like manner as a breeders’ variety,196 complemented by juicy incentives like 
exemption from paying fees for registration of farmer’s varieties, conducting DUS test, renewal 
of farmers variety, a fee for the opposition and benefit-sharing claim and no charges in court 
and administrative proceedings. The act further gives farmers the rights to hold breeders 
accountable for what they sell. That is getting compensation for the loss caused by poor quality 
seeds. It also has provision to protect farmers from spurious seeds, unfair marketing practices 
and exaggerated claims by seed companies and disregard rights for claiming compensation if 
the breeder willfully and knowingly fails to disclose the actual identity or parental line or 
knowledge while registering. Farmers are, however, not allowed to sell protected varieties as 
branded seeds (packaged, labelled in a way that shows that seed is of a variety protected under 
the act. 
However, under the Africa model (articles 24-27), Farmers' Rights recognises Farmers' 
varieties and breeds and protects same way and manner as the customary practices and laws 
protect them in their localities, be it formal or not, so far as there are specific attributes peculiar 
to that community.197 The DUS criteria do are not applied to farmers rights.  And Intellectual 
protection is granted through a variety certificate which gives community to the exclusive 
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rights to save, cultivate, exchange, use, sell or to license a variety’s use without prejudice to 
the Farmers' Rights.  
Section 25 in particular accord farmers, individually or collectively, the rights to save, use, 
exchange and sell farm-saved seed/propagating material of farmers' varieties and even the use 
of  a new breeders' variety protected to develop farmers' varieties. This includes materials from 
gene banks and plants genetic resource centres.198 However, farmers are prohibited from 
putting on sale materials of varieties that are protected under the law on a commercial scale. 
The Act further limits Breeders' Rights on new varieties on the basis of safeguarding the 
environment, food and health needs of the people and their communities.199 
UPOV since 61 allowed farmers to use material they have harvested from protected variety 
produced in their field for planting without any obligation to the PBR titleholder. This 
exemption is called the farmers' privilege. The 91 initially didn’t mention this, but due to strong 
opposition, this privilege has been made optional and left members national laws. The privilege 
only applies to use in one’s field and does not extend to seeds produced by another farmer. 
Hence does not permit of the seed of protected varieties to be exchanged. About 70% of farmers 
in developing countries depend on seeds produced by farmers, are poor, illiterate and succumb 
to economic burden if they are forced to pay royalties on seeds they produce and use. Many 
researchers have regards farmers privilege as different from farmers rights since it has a very 
narrow scope.200 
3.3.2  THE CHALLENGES OF IPR IMPLEMENTATION 
The introduction and implementation of IPR face many challenges. And from the above, IP in 
food has not been any different, not to recount the peculiar resistance that GM faces. Some 
scholars have argued that the current IP system shows serious flaws, which become more 
apparent when global resources and the developing world are considered. The way GM has 
been treated by some courts, international bodies and treaties threatens the equitable 
distribution of resources, biodiversity and the effects on culture and economies of many nations  
 
198 FNI report 7-2006 - Farmers Rights .... http://www.readbag.com/fni-no-docpdf-fni-r0706 
199 Recognising the need to conserve the rich biodiversity of .... 
https://www.coursehero.com/file/p6bb4cv/Recognising-the-need-to-conserve-the-rich-biodiversity-of-the-
continent-the-OAU/ 
200 Esteva, G., & Prakash, M. S. (2014). Grassroots postmodernism: Remaking the soil of cultures. Zed Books 
Ltd.. 
63 
 
The issues of biopiracy, contamination, licensing, and infringements that IPRs raises threatens 
the status quo in which farmers who have total control over are the centre of the system, 
customary practice, access to seed and decision making. Farmers today on top of the 
restrictions IP comes with have to face the rigid and standardised quality control system 
designed for large companies if they want to participate in commercial seed production, and 
this is a huge obstacle. This section attempts to look at how these issues of plant-related IPRs 
in Africa are framed with possible remedies.  
BIOPIRACY is the highly unethical practice where individual and other entities through IPRs 
commercialise biological materials like plant genetic resource from various countries without 
compensation. It is often defined as “the acquisition of biodiversity, be it biological material 
like plants, animals, microorganism, and their parts, or of traditional knowledge related to 
that biodiversity, without the prior informed consent of those whose biodiversity or traditional 
knowledge has been taken”.201 Biopiracy is a significant concern in many developing countries 
and a core part of the IPR resistance movement. But proving biopiracy has been a challenge 
primarily because contracts with researchers and bioprospectors are usually not public, making 
the verification of claims  difficult even when they are stated patent claims. One can, therefore, 
not be sure that  rules of access and benefit-sharing are mandatory for bioprospectors or their 
agents. 
Monsanto's melon patent, for example, was considered as an act of biopiracy which violated 
the Indian law and international treaties because the patented resistance feature was not 
invented by Monsanto, instead just discovered in an Indian melon.202 The Hoodia biopiracy 
example where the exclusive rights to the appetite suppressant technology that is based on the 
traditional knowledge of the people of San, which was developed and patented by the South 
African Council for Scientific and Industrial Research (CSIR) were awarded epitomised how 
benefit-sharing and prior informed consent can fail in Africa.   
LICENSING - Given the nature of the Plant genetic industry, most IP holders in the GM 
industry usually resort to licensing instead of an outright sale because of the unique 
reproductive qualities. Patenting a plant is similar to licensing any other new, or novel 
 
201 Heong, C. Y. (2006). New report points to widespread biopiracy in Africa. THIRD WORLD 
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invention and product since a royalty goes to the nursery or entity that owns the patent each 
time the patented plant variety sells.203 Currently, there is a variety of licensing agreements that 
may be voluntary where the patent holder dictates the terms or Non-voluntary (Compulsory 
licensing as a mechanism for access to food is discussed further in chapter four of this paper) 
where lower royalties and transaction costs are offered. Each licensing agreement has its 
benefits and challenges. A cross-licensing, for instance, is most attractive in complementary 
patents and blocking patents cases but may not be appropriate for other situations 
Companies like Monsanto have different contractual relationships with different types of 
farmers where farmers who use the seeds are held by express license restrictions on seed bags, 
often called bag-tag-license or seed-wrap license. Certain licensing agreements prevent 
farmers from carrying out some inveterate practices for profit maximization purposes. Some 
of the agreements specify that the seed can be used to produce food and feed; such agreements 
do not permit farmers to save seeds nor replant them after harvest, but rather, they must sell 
the leftover seed as food or feed and replant.204 This type of license is likely to cause serious 
issues in Africa since the norm for most farmers is saving seeds for replanting the following 
year. 
Licensing is a common method used when research exemptions are inadequate. With it, both 
the  license holder and licensee have enough freedom to draft contracts that addresses their 
issues of interest so far as they are not anti-competitive in nature. However, licensing often 
tends to limit the rights of farmers who procure license seeds since they can only do things 
permitted under the license agreements; the license agreements are usually narrower than sales 
agreements. Even though a one-to-one licensing mechanism is a non-rigid model that leaves 
room for custom-made use and access in special cases, Overwalle G. (2006) has observed that 
users are usually the weaker party when negotiating licenses because they do not have assets 
to offer in return.205  
INFRINGEMENTS AND LIABILITIES. When the terms of a license are breached, or other 
IPR infringement happens, the patentee has the right to commence legal action against anyone 
or bodies who infringe their patents. Exploiting protected materials without the consent of the 
 
203 Plant Patent | UpCounsel 2019. https://www.upcounsel.com/plant-patent 
204 Jay P. Kesan, (2006) Licensing Restrictions and Appropriating Market Benefits from Plant Innovation, 16 
Fordham Intell. Prop. Media & Ent. L.J. 1081. Available at: https://ir.lawnet.fordham.edu/iplj/vol16/iss4/3 
205 Van Overwalle, G., Van Zimmeren, E., Verbeure, B., & Matthijs, G. (2006). Models for facilitating 
access to patents on genetic inventions. Nature Reviews Genetics, 7(2), 143. 
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owner or performing other acts which may lead to infringement. Articles 44,45,46, and 51 of 
TRIPS concerns violations of IPRs, these articles specify that members have civil, judicial, and 
administrative procedures that IPR holders can access in cases of infringements. The system 
should include remedies to prevent breaches (injunctions), fix damages caused by violations 
and provide solutions that deter others like fines and forfeitures. Several countries around the 
world have therefore instituted measures to protect IPRs from violations; however, for many 
African countries, improving IP systems to suit TRIPS standards comes with substantial 
financial costs and regulatory burdens.  
The main infringement case in the EU has been in Lemon Symphony X ZR 14/07 interpreted 
Article 13 as extending CPRV beyond the area of protected variety’s identity to the area of 
further tolerance covering its natural or expectable variation. In Melanie X ZR 93/04, the 
German supreme court decided that the whole plants cannot be seen as harvested material 
within the meaning of Article 13 since their production does not require any act of harvesting. 
The Monsanto Canada Inc v Schmeiser [2004] 1 S.C.R. 902, 2004 SCC 34 deals with innocent 
infringers. Some have suggested that even though the law demands permanent injunction in 
infringement cases, innocent infringements and situations where public interest like food 
security is at stake ought to be exempted. This is particularly important for innocent farmers 
who violate IPRs  unknowingly. 
Even though not many Infringements cases have erupted from Africa because the large portion 
of farmers is yet to diversify, the farming practice is likely to encourage infringements as more 
protected materials makes its way into the system. The light of the infringement and liability 
loophole that the pollen-drift case created  has called for the need for assessment of the current 
system in view of the objectives of improving food security and safeguarding the ecosystem, 
which can be better achieved by encouraging containment.  Luckily, the India PPVFR act 
protects innocent infringement and deems acts of breaches by farmers who genuinely were 
unaware that the infringed rights occurred when the violations happened as not unlawful.206  
The debate on how to deal with innocent infringement also brings to the fall the use of Genetic 
Use Restriction Technology (GURTS). This terminator technology as some calls it was 
introduced by the seed companies whose bid to protect the returns for their investment, often 
through contracts that forbid farmers from planting the seeds after harvest failed, particularly 
in areas where the framework for guaranteeing such protections did not exist. GURT renders 
 
206 Section 42 in The Protection of Plant Varieties and .... https://indiankanoon.org/doc/1567805/ 
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harvested seeds virile and not capable of reproducing after one season, or in some cases, “unless 
sprayed with specific chemicals that activate the right gene.” With this technology, second-
generation seeds lose the defining characteristics of the original seeds. However, the efficiency 
of GURT is often counteracted by its effects on the age-old rights of farmers to save seeds for 
planting and selling in later seasons, Hahn, R. (2012).207  
Today, many leading seed companies have refrained from GURT, especially after the measure 
was withdrawn by several international bodies indicted the measure,208 some continue to argue 
for it mainly because of the potential of resolving innocent infringements and the inability of 
some IPR systems to provide enough or cannot effectively enforce contractual clauses. The 
CBD of the UN by convention bans GURT.209 UPOV also believed that there are sufficient 
measures in Conventions and its system to “protect intellectual property rights and that with 
proper legal protections in place, technologies like 'terminator genes' should not be 
necessary.”210  
 
207 Hahn, R. (2012). Transgenic Crops in Developing Countries-Can New Business Models Make a Difference in 
Fostering Sustainability and Mitigating Non-Technological Risks from Innovation?. International Journal of 
Business Insights and Transformation, 4, 30-37. 
208 Oguamanam, C. (2005). Genetic use restriction (or terminator) technologies (Gurts) in agricultural 
biotechnology: The limits of technological alternatives to intellectual property. Canadian Journal of Law and 
Technology, 59-76. 
209 Lieberman, S., & Gray, T. (2008). The World Trade Organization's Report on the EU's Moratorium on Biotech 
Products: The Wisdom of the US Challenge to the EU in the WTO. Global Environmental Politics, 8(1), 33-52. 
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Breaking the shield; Access to IP protected GMO 
4.0.  ACCESS TO FOOD WITHIN THE GM-IP 
The problem of food security threatens the health and lives of millions of people in the Global 
South, while the reasons may be complex and inter-related, access, availability and 
affordability are crucial points that cannot be circumvented in any discussion.211 The FOA 
since 1991 has been consistent in their observations that, world food security is becoming less 
of a global supply problem, overall stability, and global stock levels, to the challenge of 
inadequate access to food supplies by the poor and vulnerable groups within a country, 
caused among other things by lack of purchasing power.212  
Many researchers point to the changes that agricultural investments witnessed as the roots of 
the challenge with access to food. Hitherto, new developments were introduced by public 
institutions and funds, but today, improved ways are generated by private entities who need 
IPRs in order to secure the returns on their investments.213 The limited monopoly rights IP 
confers on food in the form of plants, and animal varieties protections enable IPR holders to 
determine the price of food, often beyond the budget of the poor, in order to recover their 
investments. This practice, in effect, raises more significant challenges for access to food and 
food security since food security. Food security is realised "when all people at all times 
have access to sufficient, safe, and nutritious food to maintain a healthy and active life.”214 
Within the context of IP, access to food involves measures that will make protected contents 
more available to the public. And it involves limiting the monopoly on improved varieties, be 
it GM or Non-Gm, assigned to rightsholders.  
Today, many African countries are not only assuming stronger standards of intellectual 
property protection in their ‘development agendas’, but also more extensive harmonisation of 
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standards.215 While this could be of immense benefit as many argue, the likelihood of it 
negatively affecting access to food and food security, in general, exists equally.216 Many 
researchers, therefore, emphasize that granting IP protection should focus on improving food 
security and access to food in the long-term.217 As such, defining the right scope for private 
rights while safeguarding the concerns of the public when it comes to food security matters 
should be the primary consideration. Maximising the flexibility for policy space within treaty 
obligations when adopting IP protection for plants and food material, in general, becomes 
essential for nations since IPR is now a must globally.  
In this chapter, we focus on access to food by looking at how countries have approached the 
concept of access to food as defined and within the context of Intellectual Property rights by 
examining and comparing the legal protection for access to food. Since most international 
treaties operate by establishing legal standards for member states to implement within their 
territories, the specific requirements, tools, and space for national policy manoeuvres that are 
available will be perused as we look at how countries in Africa have shaped their regulations 
in this regard. 
The discussion that follows thus focuses on access to plant materials that are protected by the 
various IPRs; we first look at what access to food means and examines whether food security 
is a sufficient element in invoking relevant clauses of exceptions in treaties. We then look at 
the flexibilities or policy space offered by agreements to states and how it is affected by the 
type of protection provided by nations as a result of national obligations. Before examining and 
comparing the legal regimes that some African countries have adopted to approach the concept 
of access to food through the incorporation of the treaty flexibilities in their national laws and 
then conclude on the effects of legal protection chosen.  
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4.1. What is access to food? Does IPR restrict access? 
Access to food is one of the four elements that need to be addressed to ensure food security. it 
usually refers to how affordable food is, how they are allocated, as well as, individuals and 
households choices.218 The 2001 State of Food Insecurity Summit added the concept of social 
access to food while the CBD highlights access to genetic resource and benefit-sharing as a 
way of ensuring equity.219 The World Health Organization also considered both physical and 
economic access to food that satisfies the peoples' dietary needs and choices in the definition 
of access, and have subsequently employed many strategies to prioritise and improve access.220 
Today access to food is “Determined among consumers by the spatial accessibility and 
affordability of food retailers - specifically such factors as travel time to shopping, availability 
of healthy foods, and food prices - relative to the access to transportation and socioeconomic 
resources of food buyers”.221  
Since food access is a fluid condition of human consumers, its impact on every person may be 
different at all times. The issue of access to food manifests differently to people and in places. 
In low-income areas, it comes as the difficulty in accessing healthy and affordable food retailers 
that is within reach of one’s budget. Getting food that the people are accustomed or have the 
right nourishing ingredients to eat is also a consideration under access. To both full-time and 
part-time farmers in many farming communities across Africa, access to food comes in the 
form of the ability to produce and store enough food year in year out, and this is dependent on 
factors like access to improved seeds and planting materials.222 Access to food in Africa, 
therefore, goes beyond the proximity to food, it includes having access to the inputs (high-yield 
seeds varieties fertilisers, pesticides,) and technology irrigation, as well as the advantages of 
specialized crops and large scale farming brings, to the production of food.223  
 
218 Ericksen, P. J. (2008). Conceptualizing food systems for global environmental change research. Global 
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The current concept of access to food evokes elements that challenge the status quo and 
provoke governments to be more active in improving access to food in ways that were never 
conceived. IP as alluded earlier affect access to food in a much severe yet subtle way. It restricts 
the amount of food that can be produced in the first place, impedes research and in some cases 
acts as a tool for appropriating agriculture genetics.224 This is because many of the practices 
that are done by farmers and others in the cultivation and production of food are restricted by 
IPRs. An example is how some IPRs hinders the practice whereby farmers replants seeds they 
harvest from their farms. The use of seeds for breeding improved varieties or research is 
nowadays also hugely affected by IP. 
Some experts have argued that access to food is a fundamental human right under the right to 
food, which takes priority to many other rights including the IP which is currently one of the 
main hurdles that obstruct the access to GM foods in particular.225 Others also maintain that IP 
in and by itself promotes access since it incentivises and encourages developments that lead to 
efficient methods and higher output, but the overwhelming majority maintain that IP restricts 
access to food. And that human rights, and specifically the right to food, is a counterbalancing 
measure between the need to reward contributions of right holders and the interest of the public 
in terms of a providing an unceasing food flow.226 They believe the right to food should 
guarantee the rights of people to feed themselves in dignity through the provision of enough 
food that adequately satisfy individual needs.227 
Right to food as a concept is again a response to the challenges food insecurity places three 
levels of obligations on states under Article 11 of the International Covenant on Social, 
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Economic and Cultural Rights: first, the responsibility of preserving existing channels that 
ensure access, this includes avoiding acts that would jeopardize the current practices that ensure 
access; second, an obligation to safeguard access to food; and third, an obligation to fulfil the 
right to food conditions.228 In the context of seed policies, suggestions have been made that 
when states allow patent holders to exercise their rights in ways that detrimentally affect 
farmer’s rights in cultivation practices, including access to gm/plant material, that is needed to 
increase yield so that there will be enough food it amounts to violations.229 States, therefore, 
employ different measures to ensure these goals, however, in incorporating the right to food 
into IP in a way that facilitates access to food, other concerns like IPR and even competition 
law complicates the issue.230  
Other commentators also maintain that right to food is not an adequate legal ground that 
supersedes the right to property such as IP since the discussions do not address the 
countervailing obligations under international trade law, much less define a clear connection 
between the right to food and WTO treaties like TRIPS.231 Right to food under public 
international law, therefore, must be situated within the broader framework of international 
law, including international economic law. Moreover, the text of Article 11 of the ICESCR 
does not create a series of specific obligations for food security. Also, the view expressed on 
this particular point is usually aspirational rather than determinative.232 
The above notwithstanding, Article 8(1) of the TRIPS agreement impresses on its members to 
adopt measures paramount in protecting public health and nutrition while promoting the public 
interest in areas of extreme importance especially in socio-economic and technological 
development in a manner consistent with the agreement.233 This qualification within Article 8 
gives Article 27(3)(b) priority should a member state seek to enact a measure that would prejudice 
rights created under Article 8. This provision is vital, however, international pressures like trade 
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threats, and diplomatic intimidation is making it difficult for developing countries. So far, this 
provision has been successfully used to mitigate the adverse effects of patents in public health, 
the same can, therefore, serve as the basis for restricting protections for food. 
 
4.2  HOW CAN COUNTRIES HAVE ACCESS - FLEXIBILITIES/POLICY SPACE 
Access, be it to food or related materials, is treated differently across treaties and territories, 
while some regimes have extensive clauses on how it should be approached, others proffer 
non-binding and aspirational objectives. This situation is mainly caused by the fact that treaties 
have to find a balance between creators demanding overprotective regimes and other interest 
holders lobbying for more open systems. In this section, we look at how access clauses 
established in the relevant international treaties can and have been implemented in national 
regulations in some countries, particularly in Africa. The specific interventions and exemptions 
like compulsory license and research exemption are two flexibilities that are often employed 
and necessary for access, are assessed across treaties and legislation. 
International treaties give guidelines and states have the prerogative in determining the laws 
within their territory. Consequently, several studies have shown a positive relationship between 
nations and the conventions they are signatories to. Many countries have chosen to adopt 
different types of Intellectual property protection for plant varieties, however, as elaborated in 
chapter 3, the kind of protection offered varies over time and also from country to country, in 
line with the treaty flexibilities and general interests of the particular country.234 That is why 
during treaty negotiation stages countries makes demands in line with their national interest. 
IP protection with regards to access, therefore, varies from regime to regime  
The states that permit IP in food gives temporal monopoly rights to inventors to encourage the 
creation of new and useful works that benefit society. By this, access is restricted through 
controlling mechanisms like pricing within the protection span. States invariably limit access 
to, and the usage of new knowledge by others so that developers will be able to recoup their 
investments and to encourage more. This implies that the new development becomes available 
to all after the protected period and within that time, access is mainly dependent on the terms 
permissible by the law and determined by the right holder.  
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These Rightsholders are mostly motivated by profits, and there are instances where their 
legitimate profit-maximising interest conflicts with that of others. In such a case, the legal use 
of the protected material outside the authorisation of the rights holder depends on the type of 
protection. IP protection can be from no protection to some category, through tailored 
protection (sui generis) to stronger protection as in the case of a patent. 235  Even though the 
idea of no protection may be very unpopular today, many countries have in the past resulted in 
this mechanism. The Netherland and Germany in the past, for example, did not grant protection 
for plants,236 the United States also in the 1930s when they decided not to protect six crops.237 
In the case where a nation chooses not to protect plant genetic material or even GM, access 
will be unrestrained. However, such a move will be contrary to many existing treaties and 
conventions and will have many effects on inventions. 
4.2.1  TRIPS AND ACCESS TO FOOD 
Today, TRIPs as a pro-patent agreement broadens the scope for IP protection with a wide range 
of protections, yet scholarship on whether TRIPS encourages or restricts access to biotech 
inventions, in general, remains divided.238 The minimum standards principle that TRIPs 
stipulates means that its member states cannot implement any weaker laws. Accordingly, a 
nation can only protect plants by patents, sui-generis protection or a combination of both.239 
Patent, generally considered as the most robust protection for biotechnological invention gives 
right of exclusion, this right gives the holder the power to set prices or control access to the 
patented invention over a period. This means an invention/discovery is available to the general 
public after the period. Within this period, access to the protected materials is mostly in the 
purview of the rights holder whose primary motivation is in recouping their investments and 
not food insecurity issues. Patent, however, grants neither positive nor absolute rights; 
therefore, rights granted are subject to other regulation or further restrictions.240 
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The exponential growth of patents in agricultural biotechnology raises several concerns for 
research and development of subsistence and speciality crops, and access to the technology that 
is used in producing food, especially for poor and underprivileged groups, in less developed 
countries. There are many provisions, including the broad authority in Article 30 that allows 
patents to be limited. In addition, Article 27.3(b) lays the grounds for plants and animals to be 
excluded as a patentable subject. The inherent right to determine patentability standards allows 
countries to define what it considers as novel, inventive step, utility, and disclosure in a way 
that maximises exposure, minimise discoveries being patented and constrict patent width. This 
space can also be used in conjunction with the right to grant compulsory licenses.241  The 
research exemptions is also a model for facilitating access to patented gene technology. These 
options give countries the space to address their peculiarities.   
TRIPS incorporate a variant of the three-step test that originated from copyright law and applies 
it to patent law under article 30. This article sets out a cumulative test that a member state must 
satisfy before it can restrain the rights of patent holders or plant breeders. Even though the 
WTO leans towards the narrow interpretation of this provision its panel on the Canadian safe 
harbour provision allowed the practice where pharmaceutical companies that produce generic 
drugs to manufacture and test drugs before patents expire so that the generic drugs will be 
available as soon as the patent for the drug expires was based on art 30.242 
The layers of flexibilities that TRIPS incorporate also allows some countries to implement 
TRIPS in a way that suits domestic conditions. These flexibilities under Limitation and 
exclusion clauses thus offer a leeway to access protected materials. So far, no country has a 
justified their no patent protection for plants under Article that sets patentable subject matters 
and restriction of patent, even though many scholars have interpreted article 27(3)2 to limit the 
patent scope in plant genetics with Article 27(2) serving as a basis, for in refusing to grant 
biotechnology patents on substantial public interest grounds or to safeguard ordre public, well-
being of people and their environs. 
Other researchers have also proposed ways by which increased access is possible even without 
triggering the limitation and Exception clauses of Art 27. One such scholar is Geertruini Van 
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Overwalle, and he has offered additional routes like patent pool and clearinghouse mechanisms 
that can be employed to deal with the quagmire in crop-related patents in order to safeguard 
the right to food since few countries have utilized the flexibilities of the TRIPS Agreement to 
use, even though they allow patent for plants and others (discussed in section 4.3).243 
4.2.1.1  COMPULSORY LICENSE  
Article 31 of TRIPS establishes a compulsory licensing framework that gives WTO members 
room to implement TRIPS-compatible standards more broadly, this framework has in the past 
been used by states to obtain affordable medicines and can be used to have access to food.244 
A country can invoke compulsory license to permit the use of a patent; it can also authorise 
third parties to use a patent without the authorisation of the patent holder, but often with 
compensation. The government-imposed royalty rates are usually paid as compensation; they 
are, for the most part, lower than the rate a patent owner typically negotiate for. Compulsory 
license is available to all members, but political pressures and trade sanctions have made 
countries cautious when using this option. 
Countries that initiate compulsory licenses are, however, obliged to consider every permit on 
its individual merits, as such, the scope and duration of the license should be confined to the 
purpose for which it was authorized, and it should be done after unsuccessful efforts have been 
made with the rights holder at a reasonable commercial fees and conditions except under 
national emergencies, extreme urgency or public non-commercial use. This implies that a 
license should be in respect of specific technology, not the whole class or category. A 
government can, therefore, authorise a compulsory licensing for a particular GM variety, but 
cannot approve a compulsory licensing of all resistance to pathogens and herbicides and for 
better nutrient profiles  
The Doha Declaration which made after TRIPS guides interpreting some of the exceptions 
needed in the prior negotiation requirement. Even though the declaration is related to public 
health, its proclamations affirmed the position that member state has the discretion to decide 
the situations they consider as national emergency or circumstance of extreme urgency. A 
nation can, therefore, categorise access to food as an urgent problem and invoke the benefits 
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of this clause. Thailand, for example, has stretched this interpretation to the fury of many 
developed countries by licensing drugs that did not treat infectious diseases nor outbreak 
prevention.245  
Even though studies on compulsory licensing have focused mainly on notable factors that affect 
the issuance of compulsory licensing like local capacity, importing possibilities, and pressure 
from patent holders’ and their threats to leave the market, Son, K (2019) has observed that 
countries with matured patents systems were more likely to utilise compulsory licensing. Many 
advanced states have adopted and employed this option throughout history, although recent 
evidence shows more use by developing countries.246 Compulsory licensing is not limited to 
only patents. Thailand’s PVP and Indian PPVFR have provisions for compulsory licensing.247   
The European Parliament, for instance, has passed a resolution regarding the issuance of 
compulsory licensing for EU members. This resolution is meant to augment the provisions 
made in Art 29 the basic regulation for granting compulsory licenses for CPVR by CPVO on 
public interest grounds.248 The terms governing compulsory licenses are contained in the 
implementing rules of the basic regulation. It applies to safeguard the life and health of humans, 
animals or plants; it also aims at maintaining a consistent supply of essentials to the market, 
and the need to motivate breeders who intend to introduce improved varieties.249  
Several African countries have since 2001 issued multiple compulsory licenses for various 
reasons, but mainly under article 31 or Par7 for medicine. In some of the cases, there was no 
patent filed or granted. An example is the compulsory license Djibouti issued in May 2007 for 
HIV/AIDS, AVRs also did not have a patent granted when DRC issued the license in 2005. 
There are also instances where the licenses issued were not executed for the reasons other than 
no patent like Price discounts, rejected and also voluntary licenses. In Thailand, donations were 
the reason why the license was not carried out for the imatinib cancer treatment medication 
while Subscription model for lowering price being implemented accounted for the US non-
 
245 The United States listed Thailand in its Special 301 report. Patent holders retaliated by taking drugs off the 
market in Thailand. Despite these repercussions, Thailand did not back down from its compulsory licenses. 
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247 Son, K. B. (2019). Importance of the intellectual property system in attempting compulsory licensing of 
pharmaceuticals: a cross-sectional analysis. Globalization and Health, 15(1), 42. 
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execution on the HCV medicines in 2018. In all about 25 African countries have a history of 
issuing compulsory licenses for various reasons.250 
In West Africa, some studies have shown that the African Growth and Opportunity Act 
(AGOA) has been a significant reason for the slow initiation of compulsory licenses. Many 
countries in Africa are members of AGOA even though the initiative frustrates efforts for 
compulsory licenses, this is because AGOA highlights the enforcement of stringent IP norms. 
251  Ghana's inability to fully implement compulsory licensing in the height of the HIV outbreak 
in 2004, for example, emanates from the strict and restrictive IP-related provisions in 
AGOA.252 Together with section 104, section 111 of the AGOA and similar to 506(A) of the 
GSP Act, demands that other nations protect IPRs of US firms as stated in subparagraph (5) of 
section 502(C) of the Trade Act 1974. This measure is a core requirement that determines 
countries that will have access to US markets as well as benefit from US budgetary support.253 
Taylor M. R and Cayford J (2003) argue for a policy alternative in the US patent law that will 
allow nonexclusive licenses to developers who intends to use protected contents improve food 
security in developing countries. Such provisions, they believe, will improve access because 
developers will not have to worry about infringements when they are working on food security 
issues. They also noted that such an alternative would not significantly reduce the incentive of 
the invention since the royalty provision will ensure that rights holders are compensated in a 
way that will not make them economically is not worse off.254 
4.2.1.2  RESEARCH EXEMPTION 
Presently, research is a crucial element within the food supply sector, and it is through research 
that new and acceptable varieties are developed. Many treaties, therefore, acknowledge the 
 
250 Trips Flexibilities database http://tripsflexibilities.medicineslawandpolicy.org/ 
251 Manu, T. (2015). Assessing the potential impact of Intellectual Property Standards in EU and US bilateral trade 
agreements on compulsory licensing for essential medicines in West African States. African Journal of 
International and Comparative Law, 23(2), 226-249. 
252 Ibid. Ghana was facing shortages by the end of 2004 and this forced the then Minister of Health to declare a 
state of emergency, followed by a grant of compulsory licensing on 26 October 2005.15 Since the government of 
Ghana had declared an emergency situation with respect to the HIV/AIDS epidemic there was no need to negotiate 
for a voluntary licence from the patent right holder prior to the grant of such a licence. But did not carry out 
compulsory license. The core reason that prompted Ghana to abrogate its three-year compulsory license too soon 
stems from the fact that Combivir was patented in the US87 and this meant that such a licence had been contrary 
to the spirit of AGOA.  
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importance of research and safeguards it with an exemption. This is because the intellectual 
property rights system which was intended to encourage and reward innovation inherently 
poses a fundamental obstacle for further research, the sheer number of patents that genetic 
engineers and DNA markers, for example, have to navigate can make research and 
development of new products costly and unattractive.255 Research exemptions are therefore 
needed to provide exceptions to the exclusive rights customarily offered to patents.  
By giving researchers designated leeway to use patented materials without fear of 
infringements, researchers can develop developing cheap and culturally acceptable varieties 
that can significantly improve access to food. Research exemption is an element of patents law 
of Europe. The substantial provision, of the European Community Patent Convention, indicates 
that the rights given for a patent do not carry to deeds which are done for experimental 
purposes.256 Research exemption is also standard in some sui-generis protection. However, in 
the United States, albeit with a very narrow scope of application, research exemption is not 
stated in patent law; instead, it exists as a product of judicial decision. Over the years this 
exemption has been the centre of some notable controversies, determining the scale, nature 
(experiments on versus with) and the ultimate goal of the experiment (commercial versus non-
commercial), and where applicable have been a significant challenge.257  
Some courts in the US have construed the law in general as inherently exempting the use of 
patented inventions in non-commercial research from infringement. But in the landmark case 
of Madey v. Duke University, for example, the ruling narrowed this interpretation to exclude 
using patented technology in both commercial research  or non-research settings when it opined 
that “Regardless of whether an institution or entity is engaged in an endeavour for commercial 
gain, forasmuch as the act is in furtherance of the alleged infringer’s legitimate business and 
not solely for amusement, to satisfy idle curiosity, or for strict philosophical inquiry, an act 
may not qualify for the very narrow and strictly limited experimental use defence.”258 
Overwalle G. has, however, noted that in practice, this exemption is applied less strictly 
because companies rarely sue researchers.  
 
255 Zerbe, N. (2008). Sowing the seeds of progress: the agricultural biotechnology debate in Africa. History 
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Recent studies seem sceptical about the prospects of this exception in the area of Agri-
biotechnology.259 Many believe IPRs hinders the work of researchers who work on varieties 
for developing countries because of the unwillingness of Western biotechnology companies in 
providing the needed cooperation. Researchers particular about infringement of the patent are 
thus compelled to form partnerships with patentholders through Material Transfer Agreements 
(MTAs) to gain worry-free access to the technologies and technical know-how, this practice is 
widespread in situations where there are intentions for export. The MTAs in general strictly 
regulates the use of the technology. Some developing countries have therefore accorded 
research exemption broader limits while a number of research institutes are also granting free 
access to gene sequences used for diagnostic testing and other activities and collecting royalties 
after.  
The Indian PPVFR act does not prevent researchers from using registered variety in their works 
or experiments. It even allows registered varieties to be used as the foundation for developing 
other varieties, except that the researcher needs to the authorization of the breeder in cases 
where a variety whose parental line is needed for commercial production is used repeatedly.260 
The African model also recognises the research exemption in general as many nations within 
the continent have it in their laws. So far, no dispute has arrived over the use of this exemption 
because of the low level of research within the continent; cooperation and MTAs also account 
for this. Taylor and Cayford again argue for the laws to exclude the use of biotech patents in 
research and development aimed at food security in developing countries from the exclusive 
rights given to patents.261 
4.2.2 ACCESS IN SUI-GENERIS PROTECTIONS. 
Sui-generis protection allows countries to tailor intellectual property protections in a way that 
the challenges of a country are prioritised. A country that chooses sui-generis protection on 
plant varieties has a much wider space for manoeuvres. This is because there is no requirement 
for international standardisation as in the case of patents, neither does the law set demands that 
it should be compared to patents. Sui-Generis protection is accepted as long as there is some 
form of protection exist, even if it is not similar to any other country. This implies that each 
 
259 Covino, D., & Boccia, F. (2016). Potentialities of new agri-biotechnology for sustainable nutrition. RIVISTA 
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260 Article 30 of the Indian PPVFR 
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country is permitted to adopt any kind of protection for plant variety that will benefit the said 
county; however, many of the countries including countries in Africa that choose this form of 
protection tend to follow the path of UPOV. 
4.2.2.1 UPOV CONVENTION AND ACCESS TO FOOD 
Although many researchers question the provisions of UPOV on access to food, it is the most 
applied sui-generis system currently. The UPOV convention generally does not allow breeders’ 
rights to exceed “acts done privately and for non-commercial purposes; acts done for 
experimental purposes and; acts done for breeding other varieties” except in specific cases as 
enumerated under Article 14(5). The general interpretations under the convention give broad 
rights akin to patents to breeders and to a considerable extent limits the rights of others.  
UPOV ‘91, for example, makes farmers rights optional in art 15(2). Subsequently, many states 
have restricted farmers rights in line with this article. Further interpretation from UPOV council 
states that not a ban on farmers rights, yet following actions seem to erode farmers rights by 
the day.262 Some commentators have suggested that UPOV is the worst form of protection for 
African nations in terms of access, but increasingly, even countries like Ghana that are not 
members of UPOV are modelling their sui-generis protection along the UPOV lines.263  
Article 17 provides the sole grounds on which breeders rights could be restricted in the pursuit 
of access. It allows restrictions on breeder’s rights based on public interest grounds after 
necessary measures that guarantee the fair and appropriate remuneration for breeders’ are 
satisfied.264 However, nations that have UPOV inspired PVPs are either unwilling or have not 
been able to trigger this provision because of external pressures in spite of the eminence of 
access to food challenges in these countries. Uganda and Tanzania, for example, have different 
forms of UPOV PBR, yet both worry about access to food.265 
 
262 Winter, L. (2010). Cultivating Farmers' Rights: Reconciling Food Security, Indigenous Agriculture, and 
TRIPS. Vand. J. Transnat'l L., 43, 223. 
263 Acquah, O. D. (2019). The Proposed Plant Breeders Bill of Ghana and the Food Sovereignty Connundrum 
wpmk-the-proposed-plant-breeders-bill-of-ghana-and-the-food-sovereignty-conundrum. 
264 Restrictions on the Exercise of the Breeder’s Right (1) [Public interest] Except where expressly provided in 
this Convention, no Contracting Party may restrict the free exercise of a breeder’s right for reasons other than of 
public interest. (2) [Equitable remuneration] When any such restriction has the effect of authorizing a third party 
to perform any act for which the breeder’s authorization is required, the Contracting Party concerned shall take 
all measures necessary to ensure that the breeder receives equitable remuneration. 
265 Kakooza, A. C. (2016). Plant Variety Protection in Uganda: A Legal Analysis of Emerging Trends. 
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4.2.2.2  ACCESS TO FOOD; THE AFRICAN MODELS AND OTHER 
The African model highlights access to food by giving guaranteeing those broad rights for 
farmers. It allows farmers to save and use seed from their farm for replanting and encourages 
the exchange of seeds. The model permits for the use and sale of protected propagating 
materials for purposes other than commerce, and further allow the cultivation of varieties that 
are registered as food for household consumption or for the market. Even though these 
provisions are subject to further conditions under the Farmers' Rights, its impact on ensuring 
improved access to food is encouraging.266 In addition, article 31(d) sets forth the research 
exemption, while article 33 lays the foundation for compulsory licence rights where food 
security, nutrition or health of people are at risk.267 
The CBD-CPB has approached access from a different perspective, its provisions like Article 
15, looks at access to genetic resources from the viewpoint of States sovereignty (art. 3). States 
generally have the rights over their natural resources and are therefore entitled to a share of the 
benefits that accrue from its exploitation. The commercial utilisation of the genetic resources, 
the technology needed must, therefore, be shared on fair “mutually agreed terms”.268 Article 
16 in particular, makes provision for the access and transfer of the technologies that may be a 
subject of patents and other IPRs to be transferred fairly and in line with the overall objective 
of the CBD.269 Other sections such as article 19(4) and 20(4) detail the particulars and unique 
situation under which developing countries can have broad access, including access to IP 
related material. A number of developing countries have so far tried to harmonise their IPRs 
with the biodiversity framework. 
4.3  HOW HAVE COUNTRIES UTILIZED THESE FLEXIBILITIES 
Even though protection options vary, each option impact on access to food differently, 
available data show that many countries within Africa provide at the very least, some kind of 
protection for GM food and plant varieties. The type of protection nations have been offering 
are in practice affecting the available options for access.  
 
266 Section 31(2) 
267 Article 33 of the African model Law 
268 Art. 15.7 of CBD 
269 Article 16(2) of the CBD states that its members should recognize that patents and other IPRs can affect the 
implementation the Convention, as such each should ensure that their obligations to other treaties are supportive 
of and do not run counter to objectives of the CBD 
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Given the fact that many countries offer different forms of protection for GM and plant 
varieties, it is vital to evaluate how they have interpreted and incorporated the options above, 
especially the ones allowed for in treaties. In practice, a number of African countries have 
sought to implement the GM and plant variety legislation, yet, the question as to how well have 
they maximise the flexibilities available under these treaties that they are parties to as well as 
the factors and interests, of considerations that influence the choices they employ, remains 
potent. How have African countries applied the flexibilities available? Why? What has been 
the primary considerations, interests, and influencers?  
From chapter 3, we realised that many countries in Africa grants patents to plants and most of 
them do not only have compulsory license clauses in their regulations but have a history of 
issuing a number of them. Majority of the countries in Africa have compulsory licensing in 
their laws, usually under patent law. South Africa however, has CL in both their patent laws 
and Competition laws. Again, the majority of the countries that have successfully enacted plant 
variety laws also have compulsory licensing clauses. So far, the majority of the countries in 
Africa have experiences of issuing compulsory licenses in the health sector, even though a 
number of them were not executed.270   
Many African countries have decided to go in for protection such as patent, Plant variety 
protection, and other sui-generis protections that are not entirely in line with any international 
treaty, however, concerns are still being raised as to how specific clauses are being interpreted 
in ways that do not allow broader access. GHANA’s Patents Act 657 for example, excludes 
plant varieties from patents in section 2(g) even though part 2(f) allows for non-biological and 
microbiological materials to be patented just as in the trips agreement; Section 13 provides for 
exploitation by gov’t and other authorised persons; 271 And Section 14 handles non-voluntary 
licensing yet, its usage has been a challenge even in the heist of national crisis like the HIV 
outbreak in the early 2000s.272 Ghana is also developing a Plant breeders bill that is in line with 
UPOV even though it is not a member.273 The bill which was drafted in 2013 employs the 
typical restrictions of UPOV, even though it is not bound by the UPOV act. 
 
270 http://tripsflexibilities.medicineslawandpolicy.org/ 
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272 Manu, T. (2015). Assessing the potential impact of Intellectual Property Standards in EU and US bilateral trade 
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In conclusion, the implementation of the flexibilities is hindered by BTAs. Lauterpacht, E. 
(1996)  posits that, in being mindful of FDI and access to the perceived lucrative markets, when 
negotiating Bilateral Trade Agreements, Less Developed Countries have been reluctant in 
invoking the TRIPS flexibilities even when they have to increase affordable access 
medicines.274 His analysis will show the extent to which AGOA has shrunk the policy spaces 
of other countries that intend to implement compulsory licensing. 
4.4  OTHER METHODS THAT CAN BE EMPLOYED 
Over the years, the difficulties IP poses to access have caused many inquiries into the subject, 
and while some researchers are actively looking for new systems that can address the present 
challenges, others are dedicated to making the current system more responsive. IP as from the 
above impacts heavily on access to food, and just like IP in other fields has led to many 
advocating for more effective systems. Open-source, patent pool; clearinghouse, and liability 
regimes are some methods that have been suggested by a number of researchers as a means of 
resolving the challenge of access to protected materials relating to food. Even though some of 
these methods were first introduced in other fields, the likelihood of their successful adoption 
is high even under patents.  
Patent pool, for example, is handy when the quest for access and use of a patented technology 
requires the permission of different patent holders or multiple patents. Some researchers have 
suggested that patent pool as a better alternative to compulsory licensing. To these researchers, 
companies stand a better position and will, therefore, be more willing to corporate that 
compulsory licensing that often compels them under challenging circumstances. Taking 
cognizance of the enormity of Intellectual property in the biological diversity industry and the 
challenge it poses for a pool of patents, the Organisation for Economic Co-operation and 
Development (OECD) was the first to propose patent pool in genetics. Even though the OECD 
believed that the concept could work in this field, its proposal was more of a call for 
stakeholders’ perusal and evaluation.  
There are a number of risks associated with patent pool mechanism; one is the potential of 
concealing invalid patents. A single pool could have several patents from different sources, 
verifying each patent is an arduous task that places enormous work on pool managers. As such, 
 
Lauterpacht, E. (1996). International law and private foreign investment. Ind. J. Global Legal Stud., 4, 259. noting 
that developing countries realized that development required both public government loans as well as private 
investment flows. 
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the likelihood of admitting an invalid patent becomes high, given the workload. Secondly, 
sharing the benefits accrued from the pool among patent holders can also be challenging, even 
though the worth of each patent can be estimated by experts, the possibility of an unfair benefit-
sharing mechanism is usually high. Others have also argued that patent pools can brood cartels 
that will, in the long run, disrupt the markets with anti-competitive behaviours. The number of 
pools established so far has been able to manage these challenges mainly because of their 
moderate sizes. The golden rice pool which enriched rice with β-carotene while allows further 
genetic improvement suitable for localities, for example, shows that patent-pool can work to 
the benefit of developing countries.  
Clearinghouse mechanism is another means others have suggested that as a way to improve 
access to the genetic materials needed for food production. The term ‘clearing house’ was 
originally a barter system that some banking institutions adopted for their intra-trade activities. 
The process primarily involved transferring net balance in cash after checks and bills have been 
evened. This concept is now being employed to include any mechanism by which providers 
and users of goods, services and/or information are matched.275 So far, the clearinghouse 
system has been applied in the area of information pertaining to the status of technical attributes 
of IP. Information Clearinghouse comprises of both free and fee-paying searches like the EPO 
websites and Patent Lens. Technical exchange clearinghouses also exist to give information 
about the available technologies, their owners, and an intermediary team for license 
negotiations and mediation, BirchBod is an example of this type of clearinghouse. For now, 
the information and technical details available in these clearinghouses not only scattered, but 
they also represent a small section of the market and can only function in areas where 
technology can be delineated and valued.276 
The royalty-collection clearinghouse takes license fees from users on behalf of the patents 
holders in return for the use of specific technologies or services after which the clearinghouse 
redistributes the revenue according to an agreed formula. This model has proven its worth and 
is very common in the copyright industry. The copyright societies that monitor music played 
on the radio, and other public spaces and events are a prime example of this model. Others 
 
275 Overwalle G. Plant Patents: From Exclusivity to Inclusivity | CPVO. https://cpvo.europa.eu/en/news-and-
events/articles/plant-patents-exclusivity-inclusivity 
276  Birchbob is an internet-based platform that brings together offers and demands for innovations and provides 
services dedicated to finding and facilitating contacts between technology holders and technology seekers. 
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include the American Society of Composers, Nordisk Copyright Bureau (NCB), and the 
Southern African Music Rights Organisation (SAMRO). 
Another model available under the clearinghouse mechanism is the open-source model which 
intends to advance the open flow free exchange of technology. This model is also common 
within the software and other industries, but it is best for sharing and exchanging unpatented 
technology. The SNP Consortium is an example of an open-source method. The consortium 
has established a public directory that gathers human genomes that have not been registered 
for others who seek to use them in their research. The main challenge for this method is that 
private entities and research institutes invest so much before a gene is invented or a variety is 
developed. Therefore, like recoup before they can offer their progress for free under this model. 
The open-source model can be an excellent compliment to the research exemption.  
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5.0  CONCLUSIONS AND RECOMMENDATIONS  
The technique by which the DNA molecule of living organisms is infused artificially into other 
organisms called Genetic Modification has revolutionalised the way many things are done. 
Agricultural practices like breeding, for example, are now undertaking by artificial means to 
bring improvements. The improvements made through biotech tools include plants’ that are 
resistant to diseases, insects or drought. They also include plants that have higher receptiveness 
to herbicides or ones with enhanced qualities or upgraded nutritional benefits, as well as plants 
that produce more harvest. These improvements bring about several benefits like reducing the 
cost of production; decreasing environmental degradation; and improving the richness of food 
products that aids in the war on food insecurity, which is a real threat in Africa. 
On the other hand, significant concerns are continually being raised. Severe health issues, 
extinction of some varieties, particularly traditional ones, and the unknown perils to humans, 
animals and the biodiversity are often pushed forward to counter GM gains. Opponents argue 
that vital agricultural pollinators, decomposers, vegetation and wildlife are threatened by way 
of mutation or contamination as plants become more and more resistant and dependent on 
weedicides, insecticides and pesticides. This many believe cause farmers to become over-
reliant on seed corporations. 
Several reasons have been attributed to the slowness of Africa in accepting GM foods even 
though GM crops are traded internationally and being introduced locally by the day. This lag 
has led many countries in Africa to ignore regulations on GM instead of putting up systems 
that will curb the ills of GM. Some commentators suggest that it is essential for countries to 
regulate GM even if they do not allow it within their territories because of the growth and 
influence GM technology wields.277 In addition, given the different approaches in regulating 
GMO that the continent's trade partners have adopted, African countries have to take a stand 
and cannot be indifferent. 
A system that considers the exigencies of the time like while addressing the core issues 
pertaining to the continent like food security is most needed at this time. Health and safety-
related issues were top on the concern list; however, today, GM discourse is dominated by new 
concerns like IPR. The GM measure inherently heightens the significance of intellectual 
 
277 Ayele, S. (2007). The legitimation of GMO governance in Africa. Science and Public Policy, 34(4), 
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property protection and the ambiguities of its purpose and effectiveness on GM. This is because 
agricultural research that used to be funded by the public developed seeds that had improved 
feature which was made available to farmers as a public good are now being undertaking by 
private entities rather than the public establishments and universities. As a result of this shift, 
agricultural research is more and more being considered as private goods which need 
intellectual property protection. IPRs are necessary for the new biotech movement since 
investment needs to be recouped, yet the threat that they pose to the traditional practices have 
been a reason for the unwillingness of many in accepting the GM option. 
Intellectual Property, needs to be navigated carefully because even though it threatens the 
current practices and traditions like farming in Africa, international IP laws offer some space 
for police maneuvers in addition to the requirements they demand. Both patents and sui-generis 
protections that TRIPS offer as plants material protection mechanisms have associated 
challenges. The unresolved issues like farmers rights, licensing, infringements and liabilities 
are raised on the daily in addition to the appropriation of resources and traditional know-hows 
ranges high. While patents are too stringent, sui-generis have also been criticised as either at 
non-compactible with other IPRs or not responsive to the actual concerns’ farmers in Africa 
face, when they are in line with UPOV. However, some commentators have noted that 
something in the current IP posture needs to change. 
These challenges are, however, surmountable with the proper regulatory framework that 
prioritises the needs, concerns and aspirations of all interests. International treaties have 
provided broad and general guidelines, but a comparative study of different jurisdictions shows 
the multiple ways in which GMOs are being approached and regulated. The dichotomy 
between the US and EU regulatory systems may be a challenge for developing countries that 
have the US and EU as trade partners, but it also exposes the breadth or range of policy 
alternatives available for African countries   
Even though stability in breeding methods have improved with biotechnologies, Pila and 
Torremans believe Patent are still be ineffective for plant inventions they often tend to lack the 
novelty and inventive step patent requirements demand, thereby supporting sui generis rights 
instead. Many of the countries in Africa provide either patents or sui-generis protection for 
plants/crops in accordance with TRIPS, even though the number of countries that have finalised 
their plant variety or breeders bill is less. Such countries stand a higher chance of providing 
dual protection for GMOs. Currently, some researchers are looking for ways to improve the IP 
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system to make it more responsive to the present demands. Wijk V and Junne (1992), for 
example, believes that there is no need for Africa to adopt a patent system for plants rather, 
hybrid laws that synthesis patent law and copyright protection is more likely to work. To them, 
such a system will give broader flexibility to inventors than patents, and at the same time, a 
more limited control than copyright affords.  
This is because current IP protection is a private right as such its practices benefit the ones with 
the economic wherewithal and legal backings at the expense of those without such access. 
Many scholars have stated that the prevailing IP conventions were not formed to recognise 
informal innovators intellectual additions and the primary rationale behind the low appreciation 
for the intellectual reserve of ordinary farmers in developing countries. Therefore, finding the 
right mix IPRs for plants that prioritises the interests and positions of the continent without 
stifling investments and other interests is imperative. The effect of sweeping IPR claims 
discourages investment and innovation as well as restricts access to food. 
Access to food as an objective is possible to attain within the available system, the traditional 
modes like compulsory licensing and research exemptions are permitted under the law and 
could be employed for this purpose. While the call for indigenous communities to protect 
properties of food plant that are peculiar to them is on the ascendency, some are advocating for 
the communities to go in for royalty arrangement that is favourable. Other methods like the 
proposition by with the proposed methods suggested by Overwalle V. G. (2009) could also be 
implemented to augment the conventional methods.  
So far, the lack of a consistent and comprehensive intellectual property policy across the 
continent is not only creating many unexamined challenges that derail the progress of the 
continent but also severely disrupting many developmental goals within countries. Countries 
are drafting a new law and the ones modifying their existing laws, therefore, needs a much 
more insightful team that will consider the exigencies of their state vis-a-vis the flexibilities 
permitted within the law. This is very important because there is a considerable disconnect 
between IP and national economic-planning goals in many countries. Some have attributed this 
disconnect to the fact that most of the IP systems in Africa are relics of colonial statutes and 
decrees whose conceiving aim was not to further the goals of developing the innovative 
capacity of indigenous contributors or the preservation of the biological diversity of countries 
in Africa. 
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In general, more attention needs to be put on the capacity and capacity building within the 
region. While the need for well-equipped and fully functioning institutions are needed, more 
education, and the involvement of IP experts, etc. to negotiate competently on the international 
stage is equally crucial. The complexities of IP is very specialized and demand skilled 
personnel who are well-informed in the subject, yet there seems to be low participation of 
professional societies in the discourse within the region. Farmers, breeders, consumers and all 
interest parties along the food chain needs to be fully educated on how IP works and how each 
can benefit from it through outreach programs, school curricular, and other dedicated channels 
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